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Abstract 
Viruses are obligate intracellular parasites that need to interact with their host in 
order to replicate successfully. The understanding of this complex interaction between 
host and virus is essential for developing new therapeutic strategies as viral infections 
pose a serious challenge in healthcare, and also because viruses impose enormous costs 
on the economy. This study focused on the role of RNA interference in the interaction 
between an RNA virus (Sindbis virus) and its mammalian host cell.   
 A sensitive image–based viral replication assay was developed to follow Sindbis 
virus replication in HEK293C cells and the main anti-viral innate responses to virus 
infection described. Virus replication increased in Dicer and RNA helicase A (RHA) 
knockout cells, but not when the central regulator of interferon synthesis IRF3 was 
knocked out. High-throughput Solexa Illumina sequencing was used to detect small 
viral RNA (svRNA) in Sindbis virus (SINV) infected human cells, and to detect 
changes in the cellular microRNA (miRNA) expression profile.  Very few vsRNA 
sequences were detected by sequencing during virus infection, and I argue that they are 
random degradation products, not Dicer-generated svRNAs. Due to the very low level 
of svRNAs, these were undetectable using northern blotting. We have also found that 
the expression profile for cellular miRNAs did not change in the early stages of virus 
infection according to the sequencing data, a finding which was verified by northern 
blotting. A functional RNAi assay was developed to assess the activity and function of 
the RNAi system in cells subjected to cellular stress, type I interferon, infection and 
dsRNA, and northern blotting was used to verify the sequencing data. I have found that 
certain stress signals -double stranded RNA and SINV infection- decrease the efficiency 
of siRNA knockdowns in a siRNA-based knockdown assay system. 
I have identified two host factors important in Sindbis replication (Dicer, RHA). 
The lack of vsRNA fragments led to the conclusion that during virus infection the 
siRNA pathway is suppressed by either the cell or the virus itself, although SINV has 
been shown not to have any RNAi suppressors in previous studies conducted on its 
insect vector. This can be explained by the fact that both RNAi and the innate immunity 
detect the same molecule, dsRNA, placing these two systems into direct competition for 
the same substrate. My hypothesis is that the siRNA pathway of RNAi is suppressed so 
that Dicer does not process the long dsRNA into small, 21nt fragments, which are 
invisible to the innate immune system. 
 
Keywords: Sindbis virus, RNA interference, Dicer, RHA, Interferon, innate 
immunity, mammalian, high-throughput sequencing, virus titration 
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1. Introduction 
1.1 .RNA interference 
RNA interference (RNAi or posttranscriptional gene silencing) is the process by 
which long double stranded RNA is processed into small 21-24mer RNAs homologous 
to endogenous mRNA to inhibit expression. RNAi occurs in a wide range of eukaryotic 
organisms. It has been shown to be involved in gene expression regulation, control of 
cellular metabolism, growth and differentiation, and the maintenance of genome 
integrity, including protection of the cell against viruses and mobile genetic elements 
(Moazed 2009). Around 30% of the human genome is estimated to be controlled by a 
class of small regulatory RNA species called microRNA (miRNA), underscoring the 
significance of RNA interference (Lewis et al. 2005). Since in different organisms both 
the mechanism and the role of RNAi can be markedly different, in this short review I 
will only focus on the aspects of this process that are relevant to mammalian cells. 
Posttranscriptional gene silencing is based on small, non-coding RNA sequences 
that are partially or completely complementary to the transcript they regulate. There are 
three main classes of small regulatory RNAs: microRNAs (miRNA), small interfering 
RNAs (siRNA), and PIWI-interacting RNAs (piRNA) (Moazed 2009, Tijsterman & 
Plasterk 2004, Jinek & Doudna 2009, Obbard et al. 2009, H. Siomi & M. C. Siomi 
2009, Kutter & Svoboda 2008). The boundaries between the different types of small 
regulatory RNAs are blurred and their origin and function can be overlapping (H. Siomi 
& M. C. Siomi 2009). These molecules differ in their effector function and biogenesis, 
but are similar in chemical composition and structure, and share the same cellular 
machinery downstream of their initial processing. miRNAs and siRNAs are generated 
from long, double stranded RNA precursors, or single stranded RNA molecules with 
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extensive secondary structure, by Dicer, an RNase III family protein (Jinek & Doudna 
2009). The products of Dicer cleavage, small, 20-25bp long double stranded sequences, 
then associate with the members of the Argonaut (AGO) family of proteins. AGO 
proteins form the core of the protein-RNA effector complex, called RNA-induced 
silencing complex (RISC). Here the double stranded RNA is unwound, one strand (the 
passenger strand) is discarded, and the guide strand is used for sequence specific 
silencing of messenger RNAs (mRNAs) either by degradation, or by translational 
repression (K. Kim et al. 2007, Jaronczyk et al. 2005). Biogenesis of the piRNA class of 
small RNAs also involves the members of the Argonaute family, but it differs from that 
of the miRNA and siRNA and will not be covered in this review (Moazed 2009, Jinek 
& Doudna 2009). 
1.1.1. Biogenesis of small RNAs 
Three main categories of small regulatory RNAs have been described on the basis of 
their precursors: microRNA, small inhibitory RNA and piwiRNA. Here I am focusing 
on only the miRNA and siRNA classes of small RNAs (Figure 1.1). 
1.1.1.1. siRNA biogenesis 
Small interfering RNA (siRNA) is formed when double stranded RNA is present in 
the cytoplasm (Figure 1.1A). Dicer, an RNaseIII enzyme, generates the signature 20-25 
nucleotide siRNA fragments from their longer, dsRNA precursors (MacRae et al. 2007). 
In this respect Dicer acts as a dsRNA sensor, homologous of the RIG-I like receptors 
(RLRs), which, along with Dicer, are members of the DExD/H box RNA helicase 
family. The Dicer-generated siRNA duplexes have a phosphate group on their 5’ end, 
and a two nucleotide overhang on the 3’ end. This is a hallmark of RNaseIII mediated 
cleavage (MacRae & Doudna 2007). Dicer itself contains an N-terminal DExD/H box 
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domain, a PAZ domain, which binds to the 3’ end of the RNA molecule, adjoined by a 
connector helix to two tandem RNaseIII domains (K. S. Yan et al. 2003, Macrae et al. 
2006) (Figure 1.2). The connector helix keeps the PAZ domain at a distance of 65Å 
from the intramolecular dimer formed by the RNase domains. This molecular structure 
acts a molecular ruler, responsible for the size of the cleavage products (Macrae et al. 
2006). 
The exact substrate requirements for Dicer are not yet clear. Dicer processes the 
dsRNA into small, 21-25 nucleotide long double stranded siRNA fragments, and with 
the help of other proteins (such as RHA or TRBP, etc) loads them into a protein 
complex, called RISC (RNA induced silencing complex). In humans the siRNA is 
attached to AGO2, a member of the Argonaut (AGO) protein family (Joshua-Tor 2006, 
Meister et al. 2004). The RNA-AGO complex forms the core of RISC (Rivas et al. 
2005): the RNA molecule is responsible for target recognition, and the Argonaut protein 
forms the catalytic component (responsible for slicing or translational repression). There 
are several members of this family (the number is dependent on the species in question), 
with different small RNA specificity and enzymatic function (Farazi et al. 2008). Once 
AGO binds the guide strand of the small dsRNA, it discards the passenger strand and 
the RISC complex is ready. siRNA sequences in mammals are fully complementary to 
their mRNA targets, and induce their degradation in a catalytic manner (slicing) (Figure 
1.1A) (Doench et al. 2003, Chiu & Rana 2002, Jinek & Doudna 2009).   
1.1.1.2. miRNA biogenesis 
Similarly to siRNAs, miRNAs are short (20-25 nucleotides) double stranded RNA 
molecules, where both strand carry a phosphate group on the 5’, and a 2 nucleotide 
overhang on the 3’ end. Their biogenesis and function, however, are different from that 
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of the siRNAs (Jinek & Doudna 2009, R. J. Jackson & Standart 2007, Schickel et al.). 
The primary precursors of miRNAs (pri-miRNAs) are transcribed from the genome by 
RNA polymerase II (in some cases by RNA polymerase III). This pri-miRNA contains 
stem-loop structures that are cleaved by the microprocessor complex in the nucleus. The 
microprocessor complex contains Drosha, another RNaseIII enzyme, and its cofactor, 
DGCR8 (called Pasha in Drosophila) (J. Han et al. 2004, Gregory et al. 2004, J. Han et 
al. 2006). DGCR8 binds to the base of the hairpin of the pri-miRNA, and it positions 
Drosha to cut the stem at the distance of 11 nucleotides from the junction between the 
duplex stem and the flanking ssRNA regions (Figure 1.1B). DGCR8 is thought to be a 
trans acting specificity determinant, analogous to the PAZ domain of Dicer, which acts 
in cis. The resulting pre-miRNA is an approximately 70 nucleotide long molecule 
containing a hairpin structure. This is exported to the cytoplasm via Exportin-5, where 
Dicer completes the maturation process. After Dicer cleaved the pre-miRNA into a 21-
25 nucleotide long miRNA, it is loaded onto a RISC complex, similarly to the siRNA 
pathway, where the passenger strand is ejected, and RISC becomes operational. miRNA 
molecules in mammals are usually only partially complementary to the 3’ untranslated 
region (UTR) of their mRNA targets, and upon binding they cause translational 
repression, not slicing. The exact mechanism is not yet fully understood, but it involves 
translational inhibition of mRNA molecules, induction of de-amylation and RNA decay 
(R. J. Jackson & Standart 2007). The partial complementarily also means that one 
miRNA can suppress multiple target mRNAs (Lewis et al. 2005). There are a few 
notable differences between the miRNA and siRNA pathways in mammals. The AGO 
proteins involved in the miRNA pathway are AGO1, 2, 3 and 4. miRNA containing 
RISC does not work in a catalytic manner. While AGO2-containing RISC can process 
many target RNA molecules in the siRNA pathway (slicing), in the miRNA pathway 
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the posttranscriptional gene silencing is achieved in a slicer-independent manner. The 
RISC complex must remain bound to the repressed mRNA to maintain repression 
(Figure 1.1B) (Jinek & Doudna 2009).  
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Figure 1.1 A) An overview of the siRNA pathway: dsRNA of exogenous or endogenous origin 
is processed by Dicer into 20-23nt siRNA, and loaded onto RISC. The siRNA duplex is separated, 
and one strand is used to target complementary mRNA for degradation by AGO2. B). An overview 
of the miRNA pathway: the precursor of miRNA (pri-miRNA) is coded in the genome and processed 
by the Microprocessor complex in the nucleus into pre-miRNA, which is transported into the cytosol, 
and further processed by Dicer into 20-23nt miRNA duplexes. It is loaded onto a RISC complex, and 
used in the translational repression of target genes.  
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1.1.2. RNAi as an antiviral mechanism 
This study focuses on the role of RNAi as an antiviral defence in mammalian cells. 
The role of mammalian RNAi as an innate cellular defence mechanism against virus 
infection is not yet clear (B. R. Cullen 2006, Bagasra & Prilliman 2004a, Yeung et al. 
2007). RNAi is used against viral pathogens in plants and invertebrates (Q. Xie & Guo 
2006; Saleh et al. 2009), but mammals have a highly effective and sophisticated system 
to detect and eliminate viruses –the innate and the adaptive immune systems. Longer 
than 30mer dsRNA sequences in mammalian cells trigger innate immune responses, and 
short (20-25nt) sequences are directed towards the RNAi pathway (Tijsterman & 
Plasterk 2004; Svoboda P 2007). 
1.1.2.1. RNAi as an antiviral mechanism in insects 
It has been demonstrated that invertebrates, such as the vectors of arboviruses, 
utilize the RNAi pathway against viral infections. vsRNA sequences have been detected 
and characterized using high-throughput sequencing technologies, and were verified by 
northern blotting (Sanchez-Vargas et al. 2004; Fragkoudis et al. 2009; Myles et al. 
2009; Sánchez-Vargas et al. 2009). The origin of vsRNS can either be double stranded 
replication intermediates or single stranded RNA molecules with secondary structures, 
and depends on both the host cell and the virus. In plants, viral genomes and replication 
intermediates were described as sources of vsRNA (T. Ho et al. 2006; Molnar et al. 
2005; Itaya et al. 2007; Q. Xie & Guo 2006). In Drosophila, Flock House Virus 
infection produced an approximately equal ratio of (+) and (-) polarity vsRNA 
suggesting that the Dicer-2 substrate was the double stranded replication intermediate 
(van Rij & Berezikov 2009; Aliyari et al. 2008; Flynt et al. 2009). As cells usually 
contain much higher proportion of RNA with the same polarity as the viral genome than 
the RNA with the template polarity, sequences with the same polarity as the viral 
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genome are expected to be in the majority if the vsRNA is either produced from highly 
structured ssRNA molecules, or are the results of random degradation. vsRNA profiles 
produced by alphaviruses Sindbis (SINV) and O'nyong'nyong virus (ONNV) in insects 
showed that the vsRNA produced is overwhelmingly (+) polarity (Myles et al. 2009; 
Campbell et al. 2008). This suggests that the vsRNA is derived mostly from the 
genomic RNA or mRNA, and not from the double-stranded replication intermediates. In 
both cases hot-spots -areas of the viral genome where vsRNA was produced with a 
much higher abundance- were prominent. 
 The same study investigated the abundance of Dengue (DEN) vsRNA, and 
surprisingly it found that only 0.01-0.05% per 12 million reads mapped to the DEN 
genome. In case of alphaviruses, SINV infected mosquitoes had a significantly higher 
proportion of vsRNA (5-10%). The differences in virus evasion strategies or the 
accessibility of the viral genome may explain these differences. 
1.1.2.2. RNAi and Mammalian Innate Immunity  
In theory, RNAi (nucleic acid based immunity), which is immediately active, could 
work in conjunction with the protein based immunity, which only becomes active hours 
after the viral infection. Cytosolic short double stranded RNA sequences readily enter 
the RNAi pathway (Tijsterman & Plasterk 2004; Svoboda P 2007). The presence of 
long (more than 30bp) dsRNA, however, triggers a number of pattern recognition 
receptors (dsRNA-dependent protein kinase (PKR), RIG-I-like receptors (RLRs), Toll-
like receptors (TLRs)), and they, in turn, induce type I interferons, activate non-specific 
RNases (mainly through PKR and RNase L), and trigger a global translational shutoff 
(Ishii et al. 2008; Kawai & Shizuo Akira 2006; Koyama et al. 2008).   
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There are several arguments put against RNAi as part of the innate immune 
response. While mammals have only one Dicer gene, Arabidopsis has four, encoding 
four distinct Dicer proteins that have the potential to recognize different types of 
dsRNA (Z. Xie et al. 2004). In mammals the mechanisms helping to amplify and spread 
the RNAi signals between cells are also thought to be lacking, making the process of 
RNAi cell-autonomous (Stein 2003). 
There is mounting evidence however, that cells and viruses both utilize the RNAi 
pathway for their own purposes in mammalian systems. The host-pathogen interaction 
between is very complex and encompasses all levels of cell regulation, the RNA 
interference pathway included (Aliyari & S.-W. Ding 2009; Ben Berkhout & Joost 
Haasnoot 2006; Collins & X. Cheng 2006).  
One possible clue to the importance of the RNAi machinery during viral infections 
is that suppressing the RNAi response increases the replication rate of certain viruses. 
Plant and invertebrate viruses encode RNAi suppressors (VSRs- viral suppressor of 
RNAi), and can replicate better in cells with defective RNAi system (Vance & 
Vaucheret 2001; Aliyari & S.-W. Ding 2009). De Vries et al. reported that blocking the 
RNAi system caused the replication of several types of viruses (adenovirus, alphavirus 
and lentivirus) to increase dramatically (W de Vries et al. 2008). My own studies have 
shown similar results. 
External siRNA can be effectively used to suppress virus replication, which 
suggests that even if RNAi is not the part of innate immunity; the cellular machinery 
can be used against viral infection (J. Zhou & J. J. Rossi 2011; Joost Haasnoot et al. 
2007). 
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Viruses have evolved countermeasures against the non-specific innate immune 
responses (Randall & Goodbourn 2008) For example: Adenovirus VA sequeresters 
PKR (O’Malley & Mathews 1986), the Porcine Rotavirus NSP3 protein and the 
Influenza A virus NS1 protein  sequester dsRNA, and prevents stimulation of the type I 
interferon response (Langland et al. 1994; Bergmann et al. 2000a). HCV protease 
NS3/4A cleaves RIG-I signalling partner IPS-1 (Y. M. Loo 2006). There are several 
viral proteins (and RNA molecules) isolated from mammalian viruses identified as 
VSRs (Saumet & C.-H. Lecellier 2006; Bagasra & Prilliman 2004b; Walter de Vries & 
Ben Berkhout 2008). These proteins have diverse functions. They either interfere with 
Dicer (HIV-1 Tat), sequester and hide viral RNA (influenza NS1, Vaccinia E3L; W.-X. 
Li et al. 2004; Sullivan & Ganem 2005), or provide decoys at different stages of the 
RNAi process (i.e. adenovirus virus-associated RNAI-II is used as a decoy for Exportin-
5, Dicer and RISC). TRBP, which is important in RISC loading, also binds to HIV-I 
TAR RNA, and inhibits RNA-activated Protein Kinase (PKR), an important interferon-
activator (Gatignol et al. 2005). Several of these viral proteins can suppress RNAi in 
plant cells (Bucher et al. 2004; Lichner et al. 2003). This suppressive activity suggests 
that these viruses are targets of the RNAi machinery, and that they evolved means to 
evade it.  
Are these viral proteins real VSRs, though? An alternative explanation for the VSR 
activity of these proteins is that they could be artefacts of the experimental systems they 
were used in (Lichner et al. 2003; Umbach & B. R. Cullen 2009). The VSR role of 
mammalian viral proteins was generally studied by overexpressing them, and not in the 
context of infection. NS1, for example, is crucial for the influenza virus reproduction; 
the absence of the protein hinders virus replication. The absence of virus replication, 
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however, does not manifest in IFN-deficient cells, suggesting that the main function of 
NS1 is the evasion of the immune response (Bergmann et al. 2000b). 
Viruses have been shown to directly interact with the RNA interference machinery 
of their host cells by affecting the miRNa expression of their host cells, or encoding 
microRNAs themselves (Skalsky & Bryan R Cullen 2010; Ghosh et al. 2009). DNA 
viruses (Epstein-Bar virus (EBV; Pfeffer et al. 2004), Kaposi’s sarcoma-associated 
herpesvirus (KSHV) or cytomegalovirus (CMV) were found to be encoding miRNAs 
that regulate cellular proliferation, apoptosis and transcription. 
Cell-encoded miRNAs that block virus production have also been found, as in the 
case of miR-32 and primate foamy virus (PFV-1) (C. H. Lecellier et al. 2005). A 
potential target site for miR-32 was identified in the PFV-1 genome using computer 
analysis, and inhibition of miR-32 function in cell culture resulted in increased viral 
replication. Furthermore the viral protein tas was demonstrated to suppress miRNA-
mediated translational inhibition, supporting the role of cellular miRNAs against the 
virus infection. 
The cellular mechanisms do not always inhibit viral production. In the case of 
Hepatitis C virus (HCV), a liver-specific miRNA (miR-122) interacts with the 5’ non-
coding region of the HCV RNA, which in turn enhances virus replication (Jopling et al. 
2005). 
1.1.2.3. High-throughput sequencing in the search for vsRNA in mammalian 
cells 
The development of high throughput technologies made it possible to detect and 
sequence small RNAs (sRNAs) which are in low abundance routinely. The first, and so 
far, only comprehensive study on vsRNAs produced in mammalian cells was conducted 
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on six RNA viruses by Parameswaran et al (2010). The study used Illumina and Roche 
454 sequencing technologies to detect vsRNAs in infected invertebrate and mammalian 
cells. They have shown that vsRNA is present in some mammalian cells in an extremely 
low abundance. This has been shown to be dependent on the type of cell and virus 
studied (e.g. mouse embryonic fibroblast (MEF) and baby hamster kidney (BHK) cells 
produced a relatively large amount of vsRNAs, while dendritic cells (DC) and 
macrophages (MF) did not produce any detectable vsRNAs). The detected vsRNA reads 
may originate from two sources: they are either products of random degradation or 
Dicer activity. RNA degradation is usually characterised by a high diversity in the size 
of the resulting reads i.e. a lack of specificity for one size class is observed. The ratios 
of detected svRNAs mapping to the sense and antisense strands were different from the 
strand ratios observed in full-length virus genomes. While the full length genomic ratios 
can be from 30:1 to 100:1 (positive:negative strand) in the case of Polio, West Nile 
Virus and Vesicular stomatitis virus the observed ratios were closer to 1:1, 1:2, 
suggesting that not all of the fragments were products of random degradation. 
Dicer knockout MEF cells used in the same study showed that while the amount of 
miRNA drops over 100 fold, the abundance of vsRNA only decreased by 2.1 fold, 
which suggests that some of this RNA is produced in a Dicer independent manner. 
AGO2 knockout MEF cell lines showed an increase in vsRNA abundance relative to 
miRNA abundance; a possible explanation could be the increased stability of the 
vsRNA duplex due to the lack of AGO2, which unwinds it and discards the passenger 
strand. 
In cells where the IFN-α/β receptor was inoperable the abundance of vsRNA also 
increased relative to the miRNA abundances, suggesting a crosstalk between the IFN 
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response and the RNAi.  It is really difficult to judge if the detected svRNA sequences 
are abundant enough to be biologically relevant. Some sequences were more abundant 
than some functional miRNAs, which at least suggests that they may be functional. 
AGO pulldowns showed enrichment of vsRNA, which demonstrated that these 
sequences are loaded onto RISC. 
The study also proposed that few miRNAs consistently change in different samples 
e.g. miR-17-5p, miR-125b levels show a decrease upon virus infection, and miR-21 
level increased in immune cells. This result and findings in previous studies (B. 
Berkhout & K. T. Jeang 2007; Bryan R Cullen 2006; Ghosh et al. 2009) support the 
idea that the virus interacts with the host cell at RNAi level.  
1.2. Mammalian antiviral innate immunity 
The last ten years saw a tremendous progress in understanding how the innate 
immune system reacts to pathogens, and how it senses infection via pattern recognition 
receptors (PPR). In mammals the first line of defence against viruses is the innate 
immunity which detects either viral proteins or the genome of the invading pathogens. 
The recognition of "foreign" is based on unique molecular structures that are not 
associated with the host, called pathogen associated molecular patterns (PAMPs), such 
as single stranded DNA or RNA in the cytosol (Kawai & Shizuo Akira 2007; Koyama 
et al. 2008).   
Double stranded RNA (dsRNA) is a very important PAMP as it is produced during 
the life cycle of all RNA viruses either as a replication intermediate or a self-
complementing single stranded RNA. dsRNA is detected by several PRRs: Protein 
Kinase R (PKR), which causes translational inhibition and the enhanced transcription of 
interferon stimulated genes (ISGs) (B. R. Williams 1999), cytosolic RIG-I-like receptor 
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(RLR) family, which triggers the type I interferon  response (J. Zou et al. 2009) 
(Nakhaei et al. 2009). The membrane-bound Toll-like receptor (TLR) 3, 7 and 8, are 
also important, which upon activating IRF3 NFκB and ATF2-c-Jun, trigger the type I 
interferon response (M. S. Jin & J.-O. Lee 2008). 2'-5' oligoadenylate synthetase (OAS) 
family activates RNase L leading to translational inhibition and apotosis (Levy & 
Garcia-Sastre 2001). 
The function of these receptors is redundant and overlapping with additional 
feedback loops built into the signalling cascades. The result of activation is the 
triggering of type I interferon response, pro-inflammatory cytokine production, 
translational shutoff, a general antiviral state in both infected and neighbouring cells and 
apoptosis and trigger the adaptive immune system (Koyama et al. 2008; Ishii et al. 
2008; PERRY et al. 2005; Haller et al. 2006) 
1.2.1. Recognition of viruses by DExD/H box helicase RLRs 
Most cells in the body use the so-called classical (or TLR independent) pathway for 
interferon signalling, which involves RLRs instead of TLRs. The intercellular sensors 
involved in this pathway detect viral signals upon infection (replication dependent 
detection), and activate the main interferon regulatory factors, IRF3 and NF-κB. This 
results in IFN-β production as an initial response, then switches to IFN-α during the 
subsequent amplification phase through IRF7.  
One of the most important intracellular viral sensor families is the RIG-I-like 
helicase family. RIG-I (retinoic acid-inducible gene-I) and MDA-5 (melanoma 
differentiation-associated gene-5) are closely related cytoplasmic proteins, and they 
both belong to the DExD/H box helicase family. Their domain structure is similar: they 
consist of two N-terminal CARD domains (Caspase recruitment domains), which are 
responsible for signalling. A central ATPase, helicase domain serves to bind and 
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possibly unwind RNA (it is a DExD/H-box RNA helicase domain, similar to the one 
found in Dicer), and a C-terminal domain with an embedded repressor domain, which 
functions in autoregulation of the receptor molecule, and might be involved in target 
recognition (Yoneyama et al. 2004; Yoneyama et al. 2005) (Figure 1.2). LGP2 
(Laboratory of genetics and physiology) closely resembles RIG-I and MDA-5, but it 
lacks the CARD domains of the latter. It was initially thought to function as a negative 
regulator of the host’s defence based on in vitro studies (Rothenfusser et al. 2005). Mice 
knockout models demonstrated however that depending on the infecting virus, and 
possibly the cell type, LGP2 can serve as positive regulator/co-receptor as well 
(Venkataraman et al. 2007). 
Knockout models have demonstrated that RLRs are essential for type-I IFN 
response in most non-immune cell types, and that despite of being closely related, their 
functions are not redundant (Hiroki Kato et al. 2006). RIG-I and MDA-5 recognize 
distinct and different viruses. RIG-I is important in recognizing hepatitis C (HCV), 
Sendai virus (SeV), influenza virus, vesicular stomatitis virus (VSV), Newcastle disease 
virus (NDV), rabies, Japanese encephalitis virus (JeV), and short polyI:C molecules. 
MDA-5 plays a role in detecting picoronaviruses, and long polyI:C molecules (Hiroki 
Kato et al. 2006; Gitlin et al. 2006). 
RIG-I recognition is dependent on the presence of trisphosphate groups on the 5’ 
end of the RNA, a characteristic of viral RNA synthesis, and not found in capped or 
processed cellular RNA (Schmidt et al. 2009). The A-form of dsRNA is also recognized 
by the receptor, irrespective of the sequence or end-modifications. Cellular RNAs, such 
as tRNAs and rRNAs are extensively modified to avoid RIG-I recognition. The RNA 
ligands recognized were characterized by Schmidt et al (2009) and Schlee et al. (2009). 
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They have found that the 5’-triphosphate end is not sufficient on its own. A blunt ended 
region of dsRNA adjacent to the 5’triphosphate group is also needed (Schmidt et al. 
2009; Schlee et al. 2009). Hantaan virus, Borna virus, and Crimean-Congo hemorrhagic 
fever virus are able to avoid RIG-I recognition by modifying their 5’ triphosphate 
groups (Habjan et al. 2008). Short dsRNA chains (about 31bp) with a minimum of 
single phosphate group on either ends can also trigger RIG-I recognition 
(Bürckstümmer et al. 2009; Baum et al. 2010). RIG-I also recognizes particular 
sequences within the RNA; uridine and adenosine-rich regions were shown to be 
preferentially bound by RIG-I, and these regions are found within the PAMP structure 
of a number of viruses (Saito et al. 2008; Uzri & Gehrke 2009). RIG-I also can 
recognize RNase L cleavage products which might serve as an amplifying mechanism 
for RLR signal transduction (Malathi et al. 2007).  
MDA-5 was initially thought to detect long linear dsRNA. Long dsRNA (longer 
than 1kb) is indeed capable of induce MDA-5-dependent type-I IFN response, but at the 
present the accepted model is the recognition of higher-order RNA structures containing 
both ssRNA and dsRNA. These mesh-like structures are generated during the viral life 
cycle, and thought to be the primary ligands of MDA5 (A. Pichlmair et al. 2009). 
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Figure 1.2 Domain Structure of selected DExH/D box helicases. RIG-I: tandem CARD domains, 
which are responsible for signalling, a central DExH/D box helicase domain, which has ATPase activity, 
and binds (possibly unwinds) the RNA ligand, and a C-terminal domain with a repression domain 
embedded, which is responsible for autoregulation and for target recognition. RNA Helicase A: two N-
terminal dsRNA binding domains (dsRBD) amd a C-terminal domain are flanking the central DExH/D 
box helicase domain. The C-terminal domain has an RGG box (often found in RNA binding proteins, and 
contains repeats of Arg—Gly—Gly) The C-terminal also has a bidirection nuclear transport domain. 
Dicer: DExH/D helicase domain which has the possible functions of unwinding RNA, translocating 
Dicer, or facilitating handoff of products. DUF domain is of unknown function. PAZ (Piwi-Argonaute-
Zwille) domain binds the end of the substrate dsRNA. Connector helix sets the length of the RNA 
fragment by placing the PAZ domain and the RNaseIII domains 65 Å from each other. Tandem 
RNaseIIIa domains are responsible for the cleavage of the substrate dsRNA. dsRBD domain presumed to 
participate in pri-micro-RNA recognition and sub cellular localization of Dicer.  
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1.2.2. The RLR signalling pathway 
Signalling through RIG-I is tightly regulated by its C-terminal domain. Without 
ligands to bind, the molecule is in a "closed" formation, and only undergoes a 
conformational change upon ligand binding. This opens up the molecule, and the freed-
up CARD domains appear to bind to free ubiquitin chains, which, in turn, induces the 
multimerization of RIG-I. These higher-order complexes of RIG-I and ubiquitin are 
strong inducers of type I interferons. They interact with the CARD domains of 
MAVS/Cardiff/IPS-1, and induce a signalling cascade which will trigger the 
transcription of interferons and ISGs. Although the activation of MDA5 is not as well 
studied as RIG-I, it is known that both MDA5 and RIG-I signal through mitochondrial/ 
peroxisomal MAVS via their CARD domains. MAVS is a critical anti-viral protein in 
the signalling pathway (Seth et al. 2005; Sabbah et al. 2009). It consists of an N-
terminal CARD domain, a proline-rich region and a C-terminal hydrophobic 
transmembrane region that anchors it to the peroxisomal and outer mitochondrial 
membrane (Dixit et al. 2010). (The membrane attachment is crucial for the function of 
the protein; deletion mutants fail to induce the interferon response. HCV specifically 
targets the C terminal domain of MAVS for cleavage, further pointing to the importance 
of membrane attachment.) The exact mechanisms of how MAVS signals to downstream 
kinases are not fully understood yet. The binding of dsRNA to RIG-I induces a 
conformation change, and enables it to bind to MAVS via the CARD domains. MAVS, 
in turn, signals to both NF- B and IRF3 signalling pathways by activating the IKK and 
TBK-1/IKK  kinase complexes. IRF3 is constitutively expressed in the cell, while IRF7 
is induced by type-I IFNs. NF- B and IRF3 translocate into the nucleus and turn on the 
expression of inflammatory cytokines, IFN- , and other ISGs. The central function of 
IRF3 is underlined by the fact that many viral IFN inhibitors target it as the type-I IFN 
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response is impossible without it (Seth et al.; O. Takeuchi & S. Akira 2009) (Figure 
1.4).   
IFN-  acts in an autocrine and paracrine manner, and activates the second round of 
IFN signalling, which –among other proteins- turns IRF7 production on, amplifying the 
interferon response. ISGs are activated by both IFN-dependent and independent manner. 
IFN-dependent ISGs are induced through the JAK/STAT pathway. Some ISGs can be 
up regulated without IFNs; this was shown to be mediated by peroxisome-bound 
MAVS, while the IFN-dependent ISGs had a delayed activation through the 
mitochondria-bound MAVS signalling pathway (Schoggins & Charles M Rice 2011; 
Dixit et al. 2010). There are hundreds of ISGs with very diverse functions: some act as a 
negative or positive regulator of the IFN response, some target viral replication acting at 
every step of the virus life cycle collectively. It seems that many have overlapping 
functions, which builds redundancy into the defence system. Most ISGs have relatively 
moderate inhibiting effects on virus replication; it appears that many, moderately 
inhibitory ISGs are safer for the cells, than a selected few with strong inhibitory effects 
(Schoggins & Rice 2011)(Figure 1.4). 
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Figure 1.3 Signalling pathway of the RIG-I like helicases induces interferon and inflammatory 
cytokine production. Upon detecting viral RNA the inactive ("closed") RIG-I activates ("opens"), and 
the CARD domains bind to ubiquitin (Ub)chains resulting in the multimerization of RIG-I. This activated 
molecule can interact with the CARD domains of MAVS, which, in turn, activate the NF- B and the 
IRF3 pathways through TBK1/IKK kinase complexes. NF- B and IRF3 migrate into the nucleus where 
they trigger the transcription of inflammatory cytokines and type I IFNs, respectively. 
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Figure 1.4. Activation of interferon induced antiviral state by virus replication Incoming viruses 
are sensed by several PRRs (Viral RNA is sensed by TLR-3 in endosomes, PKR/RIG-I receptors in the 
cytoplasm), which, in turn, starts a signalling cascade in the cell to produce and secrete type I IFNs. Type 
I IFNs induce the synthesis of ISGs through the JAK/STAT pathway. Some ISGs are induced via an 
interferon-independent pathway (thin blue arrow). ISGs are involved in inhibition of viral reproduction 
(thick red bar), but some can enhance virus replication (green arrow). In addition, several ISGs target 
parts of the innate immune response (PRRs, IFRs, etc) as a negative feedback loop.  
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1.3. Sindbis virus 
1.3.1. Classification and structure 
Sindbis virus (SINV) is a well-established laboratory model for alphavirus infection. 
It belongs to the Togaviridae family, and alphavirus genus. There are three subgroups in 
the genus:  Semliki Forest virus subgroup (Semliki Forest, O'nyong-nyong and Ross 
River viruses); the eastern equine encephalitis virus subgroup (eastern equine 
encephalitis and Venezuelan equine encephalitis viruses) and the Sindbis virus 
subgroup. 
The hosts of SINV are small mammals and birds; humans are considered dead-end 
hosts. In humans SINV causes arthralgia syndrome, high-titre viremia, and mild to 
severe fever.  
The virus is an enveloped virus of about 65-70 nm in diameter, with an icosahedral 
nucleocapsid (NC). (Figure 1.5A-B.) It has a single stranded RNA of positive polarity 
of 11.5kb length, which is capped and polyadenylated, and serves as an mRNA 
molecule. (Figure 1.5C.) The virus encodes four nonstructural proteins (nsp1-4), which 
are important in virus replication, and five structural proteins (capsid, E1, E2, E3, 6K) 
translated from the subgenomic 26S RNA. (Flint 2004) The viral envelope is a host-
derived lipid bilayer, in which 240 copies of E1 and E2 transmembrane glycoproteins 
are embedded. (Figure 1.5 B.)  The virus envelope also contains small amounts of 6K 
viral protein.  
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Figure 1.5. Structure of Sindbis virus. A.) Structure of Sindbis virus at 20Å resolution determined 
by X ray crystallography and 3D image reconstruction techniques. B.) Cross section of Sindbis virus at 11 
Å resolution showing the glycoproteins (E1 and E2), the lipid bilayer, and the viral capsid (NCP) by cryo-
EM C.) Schematic drawing of Sindbis virus genome organization. The virus genome is a single stranded 
RNA molecule with positive polarity. It is capped and has a polyA tail, which enables it to function as an 
mRNA molecule. The non-structural proteins are translated from the 49S full length genomic RNA as 
nsp123 and nsp1234 polyproteins which undergo cleavage during maturation  by snP2. nsP4 is 
responsible for the RdRP activity of the SINV replication complex. The structural proteins are transcribed 
from the 26S RNA promoter as a polyprotein, and undergo processing and cleavage in the cytosol/Golgi 
apparatus. Numbers above or below the proteins show their positions on the genome. (Image adopted 
from (Linssen et al. 2000)) 
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1.3.2. SINV replication 
Virus entry is facilitated by a wide range of cell surface receptors (Figure 1.6.). E2 
glycoprotein is responsible for virus-receptor interactions. The exact nature of receptors 
is still not known; what is clear is that the virus entry is a two-step, receptor mediated 
process.  The first step is a highly dynamic binding process, while the second is a high-
affinity binding and attachment, with reduced viral mobility, followed by viral 
endocytosis (Gu et al. 2011). Alphaviruses are capable to infect a wide range of hosts, 
and one hypothesis is that they use a conserved cell-surface receptor (e.g. laminin) to 
gain entry to the cell. Others argue that the virus is able to interact with multiple cellular 
receptors, or a combination of the two hypotheses (J H Strauss and E G Strauss n.d.). 
As soon as the virus engages with its receptor the, E2 and E1 glycoproteins undergo 
conformational changes, and the virus is endocytosed. As the pH inside the endosome 
drops, the E1-E2 heterodimer is destabilizes, and exposes a fusion peptide in E1. This 
peptide inserts itself into the endosome membrane and forms trimers. This causes 
membrane fusion, and the nucleocapsid (NC) is deposited in to the cytoplasm of the 
cell. The NC is quickly disassembled and the transcription from the viral genome can 
proceed from this point on.  
The non-structural viral proteins are translated from the full-length RNA, and can be 
detected as early as 1.5hpi. SINV -as most Alphaviruses- produce two non-structural 
polyproteins: nsp123 (1902 amino acids) and a small amount of nsp1234 (2512 amino 
acids). This latter, longer polyprotein is the result of a translational read-through of an 
opal termination codon after codon 1897 of the open reading frame, which occurs with 
about 10% efficiency. The polyproteins undergo sequential proteolytic steps during the 
course of virus reproduction. 
Nsp1 (540 amino acids) possesses both a guaninine-7-methyltransferase and 
guanyltransferase enzymatic activities which are important for the capping and cap 
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methylation of newly synthesized viral genomic and subgenomic RNA. It is also a 
membrane associated protein, and serves as an anchor for the virus replication complex 
fixing it to cellular membranes.  
Nsp2 (807 amino acids) is a multifunctional protein, which has several roles during 
virus replication. The N-terminal domain contains the helicase activity required for 
RNA replication and transcription and also responsible for the RNA triphosphatase and 
nucleoside triphosphatase activity. The C-terminal domain contains a cysteine protease 
domain, and an enzymatically inactive methyltransferase domain, which was shown to 
be important in regulating negative-strand synthesis. The protease domain is responsible 
for processing the viral non-structural proteins into their mature forms. The nsp2 protein 
also contains nuclear localization signals, and about 50% of all proteins are in the 
nucleus during infection, where they initiate host transcriptional shutoff. The 
abolishment of this signal results in attenuated virus phenotype. 
Nsp3 (555 amino acids) is required for minus-strand and subgenomic RNA 
synthesis, but very little is known about the protein and its function. 
Nsp4 (610 amino acids) is responsible for the RNA-dependent RNA polymerase 
(RdRP) activity. 
Replication takes place in cytoplasmic vacuoles which are of endosomal and 
lysosomal origin. The nonstructural proteins form dynamic replication complexes 
anchored to these membranes. The nsp1234 polyprotein undergoes a cis-cleavage by 
nsp2 at the nsp3/4 junction, which yields nsp123 and nsp4. All other cleavage happens 
in trans-position. The next cleavage happens at nsp123 between nsp1 and nsp2, 
resulting nsp1 and nsp23. These polyproteins then are able to perform the final cleavage 
at the nsp2/3 bond. It has long been accepted that the differential processing of non-
structural proteins is responsible for the changes in the activity of the virus replication 
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complexes, such as the switch from minus-strand synthesis to plus strand synthesis. 
Minus strand synthesis requires nsp123 and nsp4 in the replication complex. Nsp4 is 
rapidly degraded in the cell, and is only present in high concentration in the beginning 
of the infection. As the infection proceeds nsp123 is processed in trans into its 
individual proteins. At this point the virus switches from predominantly minus strand 
synthesis to plus strand synthesis. Plus strands are synthesized from both genomic and 
subgenomic promoter in approximately 1:3 ratios. It is not known if there are different 
replication complexes responsible for the production of the two different plus strands. 
The structural proteins are encoded in the subgenomic RNA as a structural 
polyprotein (1245 amino acids) containing CP-E3-E2-6k-E1 structural proteins (it is 
also called p130).  
The capsid protein (CP) has an autocatalytic function which enables it to undergo a 
cleavage from the nascent viral structural polyprotein. It binds to the full-length RNA 
encoding the viral genome, and assembles into icosaedric core particles, forming the 
nucleocapsid. The NC assembles in the cytosol from 240 copies of core proteins 
associated with a single plus strand genome. The mature NC interacts with the 
cytoplasmic domain of E2 and this interaction leads to budding and formation of mature 
virions. 
The autocatalytic cleavage of the capsid protein from the rest of the structural 
polyprotein chain frees up a signal sequence on pE2 which directs the rest of the 
polypeptide into the ER, where E1 and pE2 undergoes a complex conformational 
change, maturation and oligomerization. 
The function of the E3 protein is unknown. 
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E2 is responsible for the attachment of viral particle to the host cell. It is synthesised 
as a p62 precursor, which is processed by furin before it embeds itself into the cell 
membrane, and forms a heterodimer with E1. 
6K is a membrane protein which is involved in viral glycoprotein processing, cell 
permeabilization and budding of viral particles. It is only present in a very low amount 
in mature virions. 
E1 structural protein is a virus fusion protein. The protein is inactive as long as it 
forms a heterodimer with E2. After the endocytosis of the virion, the drop in pH 
destabilizes the E1-E2 heterodimer, and allows E1 to form trimers, which activates 
membrane fusion between the virus and the endosomal membrane.  
  
32 | P a g e  
 
 
 
Figure 1.6 Alphavirus replication. The virion binds to its receptors on the cell membrane, and is 
endocytosed. As the pH drops in the endosome, the virus membrane fuses with the endosomal membrane, 
and the virus capsid is released into the cytoplasm, where it is disassembled. The full length virus genome 
serves as an mRNA molecule. First the non-structural proteins are transcribed as two polyproteins: p123 
and p1234 using an opal codon readthrough. The non-structural proteins form the replication complex, 
which undergoes several proteolytic cleavage steps by nsp2. At the early stage of infection full length 
minus strand genome is produced by the replication complex, which is used as a template for the 
replication of genome and synthesis of the 26S subgenomic RNA encoding the structural proteins. These 
proteins are transcribed as a polyprotein as well. First the capsid protein is cleaved, which will form the 
nucleocapsid by interacting with the 49S SINV RNA. Meanwhile polyprotein carrying the rest of the 
structural proteins is directed to the ER and Golgi for processing and maturation, and end up embedded 
into the plasma membrane as E1-E2 dimers. E2 processed by furin just before virus budding with makes 
it able to interact with the NC proteins. The NC interacts with the E1-E2 glycoproteins, and this triggers 
the budding process, resulting in the release of virions.  (Image source: Richard J. Kuhn) 
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1.3.3. SINV infection and innate immunity 
Sindbis virus, as all alphaviruses, is an insect-borne virus, which means it has to be 
adapted to the immune system of both its host and its insect vector. It readily infects 
both mosquitoes and Drosophila, and the immune response of both insects to the SINV 
infections were studied in great detail in the last decades. It is important to point out that 
the virus needs to establish a persistent, non-pathologic infection in the vector, even 
though it usually causes an acute infection in its host organism. The difference between 
the immune systems of insects and mammals may be the main deciding factor about the 
different outcomes of infection in the different organisms. 
In insects the major immune pathway against viruses is the RNAi pathway, which 
does not lead to an acquired immune response. The insect immunity is capable of 
suppressing virus replication without the death of the infected cells. In mammals the 
primary antiviral pathway is the type-I interferon response, which triggers a signalling 
pathway leading to an antiviral state in the infected cell and the host organism itself, the 
activation of adaptive immunity, and often leads to the apoptosis of the infected cells. 
Both insect and mammalian systems sense the same PAMP: viral dsRNA. (Double 
stranded RNA is not the only virus associated PAMP, but it is a very important one.) 
In Drosophila the long exogenous dsRNA is detected by Dicer-2, and it processes it 
into 20-22nt long siRNA fragments. With the help of R2D2, Dicer-2 and siRNA are 
loaded onto a RISC complex carrying Ago2, and used in sequence specific cleavage of 
complementary, long mRNA sequences (Aravin et al. 2004; Qinghua Liu et al. 2003). 
This silencing process effectively inhibits viral replication. 
There are several pieces of evidence demonstrating that RNAi is the major antiviral 
pathway in Drosophila. First, RNAi deficient flies are hypersensitive to viral infection, 
and have increased viral titers. Second, viruses encode RNAi suppressors. Third, 
vsRNAs have been discovered and characterized in insects (Kemp & J.-L. Imler 2009). 
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Systemic RNAi spread has been demonstrated to be active in Drosophila (Saleh et al. 
2009). The rapid evolution of RNAi pathway genes compared to the miRNA pathway 
genes also suggests an on-going "arms race" between host and viruses (Obbard et al. 
2006). 
Although not as well studied, the mosquito immune system is very likely to be 
similar to the Drosophila innate immunity (Carol D. 2011; Fragkoudis et al. 2009). The 
ortholouges of Drosophila innate immunity genes have been identified in mosquitoes 
(M. Keene & E. Olson 2004). Injection of long viral dsRNA inhibits virus replication in 
mosquito cells, and knockdown of RNAi genes increased the viral titre (Campbell et al. 
2008; M. Keene & E. Olson 2004; Sanchez-Vargas et al. 2004). Even though the nature 
of the viral dsRNA Dicer-2 substrate is unknown, high-throughput sequencing 
technologies detected vsRNA in mosquito cell lines, and were confirmed using northern 
blotting (Myles et al. 2009; Cirimotich et al. 2009; Sanchez-Vargas et al. 2004). 
Most plant and insect viruses encode proteins that block one or more steps of RNAi 
to suppress the host immune response. These viral suppressors of RNAi (VSR) are very 
important in the replication of viruses (S. W. Ding & Voinnet 2007; Gordon & 
Waterhouse 2006; Feng Li & S.-W. Ding 2006). Several studies attempted to identify 
similar proteins in arboviruses, although their biology is different from insect-only 
viruses (H.-W. Li & S.-W. Ding 2005) indicated that there are no proteins encoded by 
DENG which can act as VSR. Other studies came to similar conclusions (Attarzadeh-
Yazdi et al. 2009). Inserting VSRs into arbovirus genomes showed that there is a 
significant increase of virus replication in ticks and mosquitoes (Blakqori et al. 2007; 
Garcia et al. 2006). Transgenic SINV expressing the flock house virus (FHV) VSR 
(dsRNA-binding protein B2) showed significant reduction in vsRNA and increase in 
virus RNA synthesis, virus growth, which, in turn, lead to the decreased survival rate of 
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its mosquito vector (Cirimotich et al. 2009; Myles et al. 2009). These findings suggest 
that the evolution of VSRs were not selected in arboviruses, probably to maintain the 
fitness of its vector organism.  
Evasion mechanisms of RNAi, however, seem to have been developed in 
arboviruses (Campbell et al. 2008). The sequerestation of replication complexes into 
membrane vesicles in the alphavirus family is probably one strategy to avoid RNAi 
(Sánchez-Vargas et al. 2009). In the case of FHV infection, (Flynt et al. 2009) found 
that hot-spot derived vsRNA sequences have low biological activity (probably because 
of the low accessibility for the RISC complex to secondary structures on the RNA 
molecule), which may be a way for the virus to avoid an effective RNAi response by 
overwhelming the RNAi machinery with inactive vsRNA fragments. They also found 
that many of the vsRNA molecules were not loaded onto RISC, which also could 
account for the low biological activity. Similar evasion strategy was described in plants 
(Itaya et al. 2007), and could be a way for arboviruses to evade RNAi. 
1.4. Solexa/Illumina High-Throughput Sequencing Technology 
Solexa sequencing was developed based on sequencing by synthesis (SBS) method. 
It is one of the next-generation, high-throughput sequencing technologies, which 
superseded the automated Sanger sequencing method in the last decade (Mardis 2008; 
Metzker 2009). It enables the detection of single bases as they are incorporated into 
growing DNA strands. The DNA strands first are attached to a solid surface, and 
amplified to form clusters. Four types of fluorescently labelled reversible dye-
terminators are added and imaged as each base is built into the grown DNA chain. 
These terminators are then cleaved to allow the incorporation of the next base, and the 
process is repeated (Figure 1.7). 
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1.4.1. cDNA library preparation 
Sample preparation starts with isolation of small RNA, and the ligation of special 3’ 
and 5’ adapters to the RNA chains using Illumina's kit ( Illumina - Sequencing 
Technology) (Figure A). The 3’ adapter is necessary for binding to the surface-bound 
primer in the flow cell of the sequencer, and the 5’ adapter is necessary for the reverse 
transcription and amplification of the template. After the RT-PCR and purification 
steps, the library is ready for sequencing. 
1.4.2. Cluster generation by bridge amplification 
Illumina utilizes a unique "bridged" amplification reaction that occurs on the surface 
of the flow cell. The single-stranded, adapter-ligated sample is added to the cell, where 
the 3’ end binds to the single stranded oligonucleotides immobilized on the surface 
(Figure B). The free end of the ligated fragment “bridges” to the complementary oligo 
on the surface, and is exposed to repeated denaturation and extension. This way single 
molecules form millions of clusters of the same sequence on the surface of the flow cell. 
1.4.3. Sequencing by synthesis 
Solexa technology is based on cyclic reversible termination: this method comprises 
nucleotide incorporation, fluorescent imaging and cleavage of fluorescent group from 
the incorporated nucleotides (Figure 1.7C). The first cycle starts with the incorporation 
of the first fluorescent nucleotide, followed by high resolution imaging of the flow cell. 
The signal itself identifies the location of any given cluster on the cell surface, and the 
fluorescent emission identifies which of the four bases was incorporated. The 
nucleotides have a chemically blocked 3’-OH group, making sure that in each cycle 
only one nucleotide gets incorporated into any molecule. The next step is to cleave the 
terminating group and the fluorescent dye, and the cycle is repeated one base at a time. 
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It generates a series of images representing the order of nucleotides in the sequence. 
Presently the useful Illumina reads range from 26 to 100 bases. 
 
Figure 1.7 Overview of Solexa/Illumina sequencing  (A)adapter ligation and preparation of the 
cDNA library (B) Solid-phase amplification of the cDNA library (C) Sequencing by synthesis. For 
explanation see text (source: A: Illumina v1.5 protocol manual, B, C: (Metzker 2009)) 
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2. Specific Aims 
The main aim of this study was to discover what role RNAi plays in mammalian 
antiviral innate defence. Whether RNAi is a part of the innate immune system in 
mammals is not yet clear and this study attempts to answer a few key questions. Are 
viral small RNAs produced by Dicer in mammalian cells infected with viruses? How 
does the cellular miRNA expression profile change during virus infection? Does RNAi 
have any effect on virus replication? Our main approach was the use of state-of-the-art, 
high-throughput sequencing technology (Solexa/Illumina) to investigate the presence of 
viral small RNAs (vsRNAs), and to monitor the expression profile changes of cellular 
microRNAs (miRNAs).  
The model system chosen was the alphavirus Sindbis virus, a single-stranded RNA 
virus, which is an arbovirus with a tropism for insect and mammalian cells. It has been 
previously shown that the primary mode of defence in the insect vector is RNAi, and 
vsRNA sequences mapping to the SINV genome were successfully isolated from insect 
cells. SINV is convenient for use in the lab as a class 2 virus which has no pathological 
effects on humans. Virulent non-attenuated SINV effectively suppresses the type 1 
interferon response after infection in several cell lines, an important factor to investigate 
the RNAi response in the early stages of viral infection without the modulation of an 
anti-viral response by interferon, which induces translational inhibition and apoptosis. 
 In this thesis, the question of RNAi as antiviral defence in mammalian cells will be 
addressed by: 
1. Characterizing the innate immune response to SINV infection in HEK293C cell 
line. I also studied the type I interferon response of HEK293C cells to several strains of 
SINV, and the apoptotic response to SINV strains to establish the time-frame of 
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apoptosis, as knowing the viral growth characteristics, effects on cell innate immunity 
and apoptotic processes are important for the sequencing experiments described in 
chapter 4. Since having accurate and fast virus titration was important to understand 
how host factors influence virus replication, I have developed an 
immunocytochemistry-based virus titration method that utilizes batch image-processing 
technology.  
2. To investigate the effect of host factors on viral replication. We have chosen host 
factors that are important in innate immunity and in RNA interference. We have chosen 
to investigate IRF3 because it fulfils a central role in the type I interferon response. 
RNA helicase A was chosen because it was implicated in both antiviral defence, and as 
a factor important in the replication of several viruses, and it has been shown to be 
important in RNAi as well. Dicer was chosen because of its central role in RNAi; since 
mammals have only one Dicer gene, a knockout means the complete inhibition of the 
miRNA pathway, and partial inhibition of the siRNA pathway. (External siRNA 
fragments can be loaded onto RISC even in the absence of Dicer, however double 
stranded RNA will not be processed into small RNA.) 
3. To find and characterize viral small RNA fragments in SINV infected mammalian 
cells using high-throughput sequencing technology (Solexa/Illumina), and to elucidate 
the changes in cellular miRNA expression profile of the cells during the early stages of 
virus infection. Should RNAi act as an antiviral mechanism in mammals in a similar 
manner as it does in plants and invertebrates, we expect to find large number of Dicer-
produced vsRNA sequences mapping to the SINV genome. We also expect the 
abundance of several cellular miRNAs change in response to virus infection. We have 
chosen early time points because we were interested in how the cell reacts to the 
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invading virus while it is establishing itself, and before the innate immune response 
starts, inducing an antiviral state, translational shutdown and finally apoptosis in 
infected cells.  
4. The results of the sequencing experiments showed that there are no SINV-specific 
svRNAs produced, and the miRNA expression profile of the infected cells does not 
change.  Does RNAi work in virus infected cells? Exogenously added siRNAs have 
been shown to work efficiently to silence genes when added to human cells, 
demonstrating there is an intact RNAi machinery in humans. It is well known that gene 
expression is modulated by miRNAs in mammalian  cells during development and 
tissue differentiation. Human cells express a single version of Dicer, which is 
responsible for biogenesis of both siRNAs and miRNAs. Despite of these reasons, my 
results demonstrate that RNAi does not act as an antiviral defence in human cells, 
unlike plants and invertebrates. I have set up a GAPDH knock down assay using 
GAPDH specific siRNA. This system was used to test several factors which might 
influence siRNA knock-downs. A pestiviral IFN inhibitor (N
pro
), a dsRNA homologue 
(polyI:C), type I IFN, arsenate, RHA and SINV infection were used to test the activity 
of the RNAi system.  
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3. Materials and methods 
3.1. Cells and Viruses 
All cells were maintained at 37°C in 5% CO2. HEK293C, DY8 cells (derived from 
human embryonic kidney isolate) were grown in DMEM-Glutamax (Invitrogen, 
Dulbecco/Vogt modified Eagle's medium) with 5% non-essential amino acids, 10% 
FCS and penicillin-streptomycin. BHK cells (derived from hamster embryonic kidney 
cells) were maintained in DMEM/F-12 (Invitrogen) with 5% non-essential amino acids, 
10% FCS and penicillin-streptomycin. DLD-1 Wild Type and DLD-1 Dicer-/- cells 
(colorectal adenocarcinoma cell lines) were purchased from Horizon Discovery. They 
were cultured in DMEM/F-12 + Glutamax (Gibco, 31331), supplemented with 10% 
FBS and 1% Penicillin-Streptomycin. Four different SINV strains were used in this 
study (Table 3.1). AR339: the original SINV isolate. (C M Rice 1987) Sindbis Virus 
strain AR339 was acquired from Professor Diane Griffen, John Hopkins University via 
John Fazakerly, University of Edinburgh. Sindbis Virus infectious clones TR339 was a 
gift from William Klimstra, University of Pittsburgh, TR339-GFP was a gift from Raul 
Andino, University of California, San Francisco, Capsid-mCherry tagged strains was a 
gift from Beth Levine, UT Southwestern. TR339 is a consensus “wild-type” sequence, 
possessing no or minimal cell culture adaptations, representative of the original AR339 
strain; more virulent than laboratory SINV strains (McKnight et al. 1996). TR339-
mCherry strain is a TR339 strain with a mCherry tagged Capsid protein (Figure 3.1A.). 
TR339-GPF strain is a TR339 strain that has a GFP encoding gene inserted into the 
genome; this gene is controlled by the second subgenomic (26S RNA) promoter of the 
double subgenomic SINV vector pTE3′2J, and is not fused to any viral proteins (Figure 
3.1B.). Rabbit anti-Sindbis polyclonal antibody was a gift from Sondra Schlessinger, 
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Washington University Medical School St Louis. This polyclonal antibody is an anti-E2 
antibody, but it detects E1 and capsid proteins as well.  
Table 3.1. SINV strains used in this study 
 
 
Figure 3.1. Structure of SINV TR339-mCherry and TR339-GFP. A.) SINV TR339-mCherry 
infectious clone carries an mCherry tag fused to the Capsid protein. B.) SINV TR339-GFP 
infectious clone encodes a GFP gene controlled by a second subgenomic (26S RNA) promoter. 
  
Virus strain name GENOME 
SINV-AR339 Original Sindbis isolate, cell culture adapted strain. (C M Rice 1987) (McKnight 
et al. 1996, p.339; Attarzadeh-Yazdi et al. 2009) 
 
SINV-TR339 
 
 
 
Infectious clone of AR339 with tissue culture adaptations reverse engineered to 
resemble the original SINV isolate. (W. B Klimstra et al. 1999) 
SINV-TR339-GFP Same as TR339 with a GFP-encoding gene cloned into the genome (Saleh et al. 
2009) 
 
SINV-TR339-
mCherry capsid 
Same as TR339 with an mCherry tag fused to the Capsid protein (Orvedahl et al. 
2010) 
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3.1.2. Sindbis virus (SINV) production 
All RNA and DNA samples were quantified using a NanoDrop instrument (Thermo 
Scientific). Plasmids containing the full length genome of different strains of Sindbis 
virus   (TR339, TR339-GFP, TR339-mCherry) were grown in bacterial culture, plasmid 
isolated by standard technique using Plasmid Midi kit (Qiagen), and linearized with 
XhoI (New England Biolabs) (See table 3.1.). Infectious mRNA was transcribed in 
vitro using the mMessage Machine SP6 kit (Ambion). The mRNA was transfected into 
BHK cells using Lipofectamine 2000 (Invitrogen). The media was changed after 4 
hours, and the cells were incubated for 48 hours (by the time all the cells displayed 
cytopathic effects and cell death). After incubation the tissue culture flasks were frozen 
to lyse cells, and the contents centrifuged at 3000RPM on a bench centrifuge to remove 
cell debris. The media containing virions was passaged on HEK293C cells repeatedly to 
adapt the virus to the cell line. AR339 strain was received as frozen virus stocks. 
Virions were detected by Western blot and immunostaining using an anti SINV 
antibody, or by using RT-PCR using SINV specific primers (see below). 
3.1.3. Preparation of concentrated SINV stocks 
SINV was concentrated by either ultracentrifugation, or polyethylene glycol (PEG-it; 
System Biosciences) precipitation. First the media containing the virus was centrifuged 
at 3000 RPM in a bench top centrifuge to remove the cell debris. The samples were 
pooled, and 35ml/tube were purified with centrifugation at 50 000g in an Optima XL-
100k ultracentrifuge (Beckman) with a SW28 rotor for 4 hrs. The virion-containing 
pellets were resuspended in 0.5ml OPTIMEM media (1:50 concentration), and aliquots 
were frozen in -80ºC. Alternatively after removing the cell debris PEG-it was added to 
the media in a 1 to 5 dilution and the mixture was incubated at 4ºC overnight, then the 
precipitate collected by centrifugation with 3000g for 30 minutes. 
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3.2. Immunoflurescence 
BHK and HEK293C cells were grown on 13mm coverslips, and infected with the 
various Sindbis virus SINV strains. The cells were fixed with 4% PFA at 2, 4, 8, 24 hpi, 
permeabilized in 0.1% Triton X-100,
 
and blocked in 4% BSA.  The cells were stained 
with anti-Sindbis virus antibody (dilution 1:500) for 60 min, and Alexa Fluor 488- or 
Alexa 594-conjugated secondary antibody (1:1000 dilution) for 60 min before being 
stained for 5 min with 4', 6'-diamidino-2-phenylindole
 
(DAPI) (Sigma). 
3.3. Virus Titration 
BHK cells were grown on flat bottomed, black 96 well plates used for fluorescent 
imaging, and infected with a dilution series of the virus samples. After 8hpi the cells 
were fixed with 4% PFA for 10 mins at 2, 4, 8, 24 hpi, then permeabilized in 0.1% 
Triton X-100,
 
and blocked in 4% BSA.  The cells were stained with anti-Sindbis 
antibody (dilution 1:500) for 60 min, and Alexa Fluor 488- or Alexa 594-conjugated 
secondary antibody (1:1000 dilution) for 60 min before being stained for 5 min with 4', 
6'-diamidino-2-phenylindole
 
(DAPI) (Sigma).  
Five random field of each well was imaged using an inverted microscope (Zeiss). 
The images were saved in .zvi format in Axiovision, and exported into 8bit grayscale 
TIFF files. These files were loaded into Cell Profiler for batch image analysis. Cell 
Profiler and Cell Profiler Analyst is open source software package for batch image 
processing and analysis. First the cells (their nuclei) were identified and counted using 
the DAPI channel images. To identify cell nuclei from debris and/or imaging artefacts, 
the software uses the pre-set size, shape and intensity values. The next step was to 
detect the presence of viral infection in cells, for which the signal intensity in the green 
channel was measured. The area used for measurement was defined as a diameter two 
pixels larger than the nuclei’s. This was chosen because this way closely packed cells 
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would not give false positives should a SINV infected cell’s cytoplasm be close to a 
SINV negative cell’s nucleus. Additionally, for titration purposes the actual cell shape 
or the signal intensity is irrelevant –the protocol detects positive and negative cells. 
Because only a binary measurement was needed (positive/negative), background 
correction and further image processing before analysis was not necessary. (See pipeline 
in supplementary material.) The data was loaded into Cell Profiler Analyst, where the 
cells were sorted using machine learning. In short, randomly picked cells were sorted 
manually into positive and negative categories, and the program established the sorting 
rules. After repeated testing, the whole dataset was analysed, and exported into a .csv 
file. Alternatively, black 96 well plates were used, and integrated intensity of the 
fluorescence/well was measured using a FLUOstar Omega plate reader. The data in 
both cases was sorted and analysed using Excel. The TCID 50/ml values were 
determined using non-linear regression fit with Graphpad Prism 6.0.  
3.4. One-Step Growth Experiments 
One-step growth experiments were carried out as previously described.(Flint 2004) 
Cells were infected at high MOI (8<MOI) with Sindbis virus in a low volume. The cells 
were incubated for 30 minutes at 37°C, washed with PBS and cell culture medium, and 
incubated with fresh medium at 37°C. At regular intervals samples from the cell culture 
medium were collected to assess the biological activity of SINV over time. A dilution 
series was prepared from each sample, which was used to infect BHK cells plated in 96 
well plates. At 8hpi the cells were fixed and stained for SINV, and the cells imaged 
using an inverted fluorescent microscope. The cells were counted and analysed as 
described in the previous section (Virus Titration). 
3.5. Western Blots 
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Cells were purified by centrifugation, and lysed in hot SDS lysis buffer (1% SDS 
10mM Tris pH 6.8 at 94˚C), The lysate was stored on -20°C. The samples were 
sonicated with 3 pulses lasting 10 seconds. The lysate was purified by centrifugation at 
4°C for 10 min at 15 000 g in a table top centrifuge to remove cell debris. The protein 
concentration was determined using the BCA protein assay kit (Thermo Scientific). 
50μg of protein per sample was mixed with loading buffer, denatured for 5 minutes at 
95°C, cooled on ice, and loaded onto an SDS-PAGE gel (12%). Protein separation with 
gel electrophoresis was carried out for 2.5hrs at 100V. The proteins were transferred to 
FL PVDF membrane (Immobilon, IPFL00010) using the Bio-Rad Trans Blot Semi Dry 
Transfer Cell. The membrane was incubated with rabbit-anti SINV antibody (dilution 
1:15000), and HRP conjugated goat anti-rabbit secondary antibody. The proteins were 
visualized using the Thermo Scientific SuperSignal West Pico Chemiluminsecent 
Substrate kit. Alternatively fluorescent tagged secondary antibodies were used with 
Odyssey reader (Li-Cor Biosciences). 
3.6. RNA isolation 
Trizol (Invitrogen) was used for routine RNA extraction for SINV and N
pro
 
screening, total RNA isolation and small RNA isolation. Trizol was used according to 
the manufacturer’s instructions. Cells were washed with PBS and lysed directly in the 
tissue culture dish with 1ml Trizol, and collected into 1.5 ml Eppendorf tubes. After 5 
minutes of incubation 0.2ml chloroform was added, and the samples were vigorously 
mixed. After 3 minutes of incubation the mixture was separated using a table top 
centrifuge at maximum speed at 4°C for 15 minutes, and the aqueous phase containing 
RNA (top clear layer) carefully removed, and placed into a fresh tube. The RNA was 
precipitated using isopropyl alcohol (0.5ml/1ml Trizol used). The samples were 
incubated at room temperature for 10 minutes (for small RNA the samples were 
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incubated at -20°C in isopropanol overnight), and the precipitated RNA purified using a 
centrifuge at 12 000g for 10minutes at 4°C. The RNA pellet was washed once with 1ml 
75% ethanol, and mixed by pipetting. The RNA precipitate is purified with 
centrifugation at 7.500g for 5 minutes at 4°C, the solution removed from the pellet, and 
dried for 10 minutes. The RNA was dissolved using 10-15μl RNase-free water. 
The GenElute (Sigma-Aldrich) kit was used in applications where high purity RNA 
samples were needed, such as RT-PCR, northern blotting. The mirVana (Ambion) kit 
was used for isolating total RNA for the Illumina sequencing of small RNA, because the 
mirVana kit is ideal for the isolation of small RNAs. 
3.7. RT-PCR, one-step RT-PCR 
Primers for several targets were designed using the PerlPrimer software (Marshall 
2004). ( 
Table 3.2) For RT-PCR reactions Superscript II (Invitrogen) and GoTaq (Promega) 
were used, following the manufacturers’ instructions. The starting material was 1μg of 
RNA in all cases. For the screening for Sindbis and N
pro
 expression a One-step RT PCR 
kit (Qiagen) was used. A Veriti Thermal Cycler (Applied Biosystems) was used for all 
RT-PCR reactions. Verification of primers was done by sequencing of amplification 
products (TGAC BBSRC). 
Table 3.2 List of PCR primers 
Name   Sequence Annealing 
Temperature 
(°C) 
Sindbis (-) 
Strand  
Forward GGAAGTGCTTCTCGGAGCTT 60 
  Reverse CCCTGCGTACAACACCAACT   
Sindbis (+) 
Strand  
Forward TCAGCCTCCAATTAGATACAGAC 60 
  Reverse CTTTCAACAAGTGCCTTATACGG   
β-Actin Forward CACCACACCTTCTACAATGAG 55 
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(ACTB) 
  Reverse GTGATCTCCTTCTGCATCCTG   
GAPDH Forward TGTTCCAATATGATTCCACC 50 
  Reverse CTGTAGCCAAATTCGTTGTC   
N
pro 
mCherry Forward ATGGAGTTGAATCATTTTGAACTTTTATC 60 
  Reverse  GCAACTGGTAACCCACAATGGACA   
18S RNA Forward TGAGAAACGGCTACCACATC 60 
  Reverse TTACAGGGCCTCGAAAGAGT   
 
3.8. Nucleic acid transfections  
Dharmafect 4.0 (Dharmacom), Lipofectamine 2000 (Invitrogen) and JetPrime 
(PolyPlus transfection) were all used according to the manufacturers' instructions. In 
brief, cells were plated at a plating density of 5.0X10
4
 cells/ml a day before using 
antibiotic-free tissue culture medium.  
In two separate tubes appropriate amounts (depending on the size of the tissue 
culture dish used) of siRNA and Dharmafect 4.0 was diluted in serum-free medium, and 
gently mixed with pipetting. After 5 minutes of incubation the contents of the tubes 
were mixed and incubated for an additional 20 minutes at room temperature. Sufficient 
amount of antibody-free medium was added to the tube. The medium was removed 
from the cells, and the transfection mixture was added. The cells were incubated for 24 
hrs at 37°C.  
Appropriate amounts (depending on the size of the tissue culture dish used) of 
Lipofectamine 2000 and DNA/RNA/siRNA was diluted in Opti-MEM medium in two 
separate tubes. The two tubes were mixed after 5 minutes of incubation in a 1:1 ration, 
incubated for a further 5 minute, and the DNA-reagent complex added to the cells. After 
4hrs of incubation the medium was changed to antibody-free medium, to avoid the 
cytotoxic effects of Lipofectamine. 
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JetPrime, JetPrime buffer and nucleic acid (siRNA and/or polyI:C) was mixed 
according to the volume of the tissue culture plate used (values were from the JetPrime 
protocol), incubated for 15 minutes and then added to the tissue culture medium. Cells 
were incubated for 24hrs. Optimal siRNA and plasmid concentrations were determined 
experimentally. PolyI:C (Sigma, Roche) was used in a 50μg/ml final concentration.  
3.9 Interferon Assays  
Interferon assays were conducted using the luciferase expressing DY8 cell line, a gift 
from K. Fitgerald, U Mass, Worcester, MA. DY8 cells are HEK293C cells transfected 
with the luciferase gene under the control of three Interferon-Sensitive Response 
Elements (ISREs), which ensures that type I interferon signal leads to the production of 
luciferase in a dose dependent manner.  
Supernatant from cell treated with SINV or polyI:C was heat inactivated at 50°C or 
UV inactivated (to inactivate SINV virions present in the tissue culture medium), and 
added to DY8 cells. The cells were incubated for 8hrs the supernatant. Over this time 
the type I IFNs released by cells treated with SINV/polyI:C activate luciferase 
expression controlled by ISRE present in the DY8 cells. After the incubation period 
DY8 cells were lysed, and the lysate was stored in -20°C until use. The luciferase assay 
was performed using 30μl of lysate with 30μl of luciferin substrate in a 96 well white 
plate. The luminescent signal was read using an EnVision 2103 multi-label plate reader 
(Perkin Elmer) at 590nm. 
 3.10. High Throughput Solexa sequencing 
High-throughput sequencing was carried out as previously described (Szittya et al. 
2008). Total RNA was isolated from the samples using the miRvana
TM 
miRNA isolation 
kit (Invitrogen). The kit is formulated to isolate the small RNA population along with 
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total RNA combining the advantages of organic extraction with solid-phase extraction. 
The next step was the ligation of adapters of the Illumina kit on both the 3’ and 5’ end 
of the small RNA molecules using Illumina Small RNA Sample Preparation Protocol 
v1.5. This modified protocol was developed by Illumina to specifically enrich the 
library in miRNA and siRNA. The v1.5 small RNA 3' adapter is specifically modified 
to target microRNAs and other small RNAs that have a 3' hydroxyl group resulting 
from enzymatic cleavage by Dicer. Following this step the samples were amplified by 
an RT-PCR step with the adaptor-specific primers provided in the Illumina kit. The 
PCR product was separated on a native 8% PAGE gel, and stained with Ethidium 
Bromide. The bands corresponding to the adapter-ligated product (21-31 bp small RNA 
+ 75bp both adaptors) were excised at the 100bp band of the ladder, and purified from 
the gel. This small RNA library was sent for sequencing to BaseClear, The Netherlands. 
Isolated small RNA populations were sequenced with the Illumina/Solexa Genome 
analyser (Mardis 2008; Metzker 2009;  Illumina - Sequencing Technology). 
3.11. Data analysis 
Data analysis was performed by Dr Irina Mohorianu (Dept. of Computational 
Biology). The preliminary analysis of the sequenced libraries was conducted using the 
UEA sRNA Workbench (Stocks et al. 2012). The adaptor removal, quality check and 
genome matching were conducted as described by Irina Mohorianu et al. (2011). The 
accepted reads were mapped full length, with no mis-matches against the human 
genome, or full length with up to 2 mis-matches against the SINV genome. The 
normalization was conducted using the proportional scaling approach, “reads per 
million” (RPM) (Mortazavi et al. 2008). The identification of miRNAs was conducted 
using miRCat (S. Moxon et al. 2008), with standard parameters for human samples and 
miRprof using as input all mature and precursor sequences of miRNAs deposited in 
51 | P a g e  
 
mirBase (Griffiths-Jones et al. 2008). The statistical analysis of the properties of sRNAs 
was conducted in R using the standard stats package. 
3.12. Northern Blotting 
3.12.1. Total RNA blots 
Total RNA was isolated from samples using either Trizol (Invitrogen), or the 
GenElute (Sigma-Aldrich). Electrophoresis, transfer and blotting were performed as 
previously described (Sambrook 2001). In short 5 micrograms of each RNA sample was 
resolved in a 1% denaturing agarose gel, and transferred to a nylon membrane (BioRad) 
overnight. After UV crosslinking the membranes were hybridised overnight in 
ULTRAhyb hybridisation buffer (Ambion) with ɣ-ATP labelled primer probes 
(incubated at 42°C), and imaged using Fuji phosphorimaging screen. Densitometric 
analysis of the northern blot images was carried out using QuantityOne (Bio-Rad) 
(Table 3.3). 
Radioisotopes were purchased from Amersham, UK. 
3.12.2. Small RNA blots 
RNA from samples was isolated using either Trizol (Invitrogen), or the mirVana kit 
(Ambion). Electrophoresis, transfer and blotting were performed as previously 
described (Pilcher et al. 2007). In short 10 micrograms of each RNA sample was 
resolved in 15% denaturing PAGE gel, and transferred using the semi-dry method onto 
nylon membranes (BioRad). After chemical crosslinking the membranes were 
hybridised overnight in ULTRAhyb-Oligo hybridisation buffer (Ambion) either with ɣ-
ATP labelled primer or LNA probes (incubated at 37°C) or with α-CTP labelled 
riboprobes (incubated at 64°C), and imaged using Fuji phosphorimaging screen (Table 
3.4.). 
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Table 3.3. List of primer probes used for total RNA northern blotting 
Probe name Sequence 
GAPDH probe GGCATGGACTGTGGTCATGAG 
SINV genomic and 
subgenomic primer 
probe sequence 
(position7568-7631): 
GTATTAGTCAGATGAAATGTACTATGCTGACTATTTAGGACCACCGTAGAGA
TGCTTTATTTCC 
18S RNA probe TTACAGGGCCTCGAAAGAGT 
 
Table 3.4. List of miRNA primer probes used for northern blotting 
let7 AACTATACAATCTACTACCTCA 
miR182 GTGTGAGTTCTACCATTGCCAAA 
miR100 ACAAGTTCGGATCTACGGGTT 
miR92 GGAGGCCGGGACGAGTGCAATA 
miR378 GCCTTCTGACTCCAAGTCCAGT 
miR424 TCAAAACATGAATTGCTGCTG 
miR19 TCAGTTTTGCATGGATTTGCACA 
miR34 ACAACCAGCTAAGACACTGCCA 
MiR196 CCCAACAACATGAAACTACCTA 
miR769 GCTCAGAACCCAGAGGTCTCA 
miR197 GCTGGGTGGAGAAGGTGGTGAA 
miR10  ACAAATTCGGTTCTACAGGGTA 
miR378 GCCTTCTGACTCCAAGTCCAGT 
miR29a TAACCGATTTCAGATGGTGCTA 
miR155 ACCCCTATCACGATTAGCATTAA 
U6 TCATCCTTGCGCAGGGGCCA 
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4. Host Factors Involved in SINV Reproduction 
4.1. Overview 
The interaction between host and virus is crucial for successful replication. Host 
factors may be beneficial or detrimental for virus infectivity and replication.  The 
expression or absence of host factors in cells governs whether the virus survives.  This 
chapter describes the establishment of the virus infection model using Sindbis virus. 
Two immunocytochemistry-based virus titration methods were used to quantitate the 
virus. One is an imaging-based method that utilizes batch processing and machine 
learning, and the other is a fluorometric method based on multiwell-plate readers. I have 
used the titration methods I developed to investigate whether important cellular factors 
including Dicer, interferon regulatory transcription factor IRF3 and RNA helicase A 
(RHA) influence the replication and survival of SINV in HEK293C cells. Interestingly I 
have discovered important novel results which show that s that Dicer and RHA activity, 
but not IRF3 modulate the efficiency of SINV replication in mammalian cells. 
4.2. Introduction 
Sindbis virus is a widely used model system of virus-host interaction due to its wide 
host-specificity, simplicity of production and use. We have chosen it to study viral host 
interactions on the level or RNA interference, as it has been shown not to encode VSRs 
in mosquitoes, and as a single-stranded RNA virus, it offered the highest probability for 
production of vsRNAs. 
4.2.1. Preparation and characterization of SINV stocks 
In order to able to reproducibly infect cells with SINV at a consistently high titre in 
replica experiments, and to monitor the kinetics of virus replication, a fast and non-
biased method for the characterization of SINV stocks was needed. In these experiments 
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different SINV strains were used, including AR339, TR339, and fluorescently tagged 
infectious clones SINV TR339 GFP and SINV TR339 Cherry Capsid (See Table 3.1), it 
was also important to determine if these strains had similar growth characteristics.  
RT-PCR, immunocytochemistry and western blotting were used as sensitive 
methods to detect viral nucleic acids and replication in cells and viral proteins, 
respectively. SINV-GFP strain was used as a simpler method to detect viral infection, 
than immunofluorescence with an anti-viral antibody, as the fluorescent tag makes it 
possible to identify virally infected cells by observation under a fluorescent microscope. 
An advantage of SINVTR339-GFP over SINV TR339-mCherry was that the GFP is 
inserted into the infectious clone under the control of a second subgenomic promoter. 
Fusing fluorescent tags to viral structural proteins can have a negative effect on viral 
replication (Figure 3.1.). In the case of SINV TR339-mCherry infectious clone, the tag 
is fused to the capsid protein. This strain has a decreased replication rate, due to 
impeded capsid protein folding and assembly of virions. We have observed that this 
strain grows slowly, has a delayed response in apoptosis, and it also loses the mCherry 
tag with increased passage number in tissue culture. 
4.2.2. Imaging-Based Virus Titration methods 
The measurement of viral growth kinetics required a sensitive titration method. 
Because virus preparations contain imperfectly formed virions, called defective 
interfering particles  (DI’s) , methods that measure the amount of viral RNA or protein 
(qRT-PCR, northern blotting, ELISA, western blotting) do not correspond with the 
infectious dose of virus  (measured as TDIC 50). Biological activity is measured with 
plaque assays and endpoint dilution assays, both of which are expensive and time 
consuming, or not possible with non-plaque forming viruses, or viruses not causing 
cytopathic effects in their host cells.  
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Based on previous biological assays with the use of anti-SINV antibody, I 
developed two different methods to allow for a faster, easier quantitation of virus 
samples. Also, due to the use of computer-based batch processing, the observer bias has 
been reduced in these methods. 
4.2.3. Virus-host interactions 
To characterize some aspects of virus-host interactions, we have investigated the 
innate immune response to a positive stranded RNA virus (SINV) infection, and the 
effects of several host factors on virus replication. 
4.2.3.1. SINV and Innate immunity 
The main focus of this study is the way SINV interacts with the RNAi machinery, 
because it is not yet clear what role mammalian RNAi plays in antiviral defences. One 
hypothesis is that the evolutionary newer innate and adaptive immunity replaced RNAi, 
and it has only gene-expression regulatory roles in mammalian cells. To be able to 
assess how cell-autonomous innate immunity (the type I IFN response) works in 
mammalian cells in response to SINV infection, I have used luciferase interferon assay. 
It was important to understand the dynamics of host-SINV interaction for this study. I 
needed to make sure the cells were not in antiviral state at the time point when we 
assessed the activity of the RNAi system. The antiviral state, induced by interferons, is a 
complete translational inhibition in the cell, along with the induction of apoptotic 
pathways. It has also been reported that Dicer is down regulated in response to IFN 
stimulation (Wiesen & Tomasi 2009), pointing to the possibility that genes important in 
RNAi are down regulated, and RNAi is inactive in cells in antiviral state.  
4.2.3.2. Role of Cellular Factors in virus replication 
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In order to understand factors that affect SINV replication and secretion, and which 
antiviral pathways may be inhibiting different aspects of the SINV life cycle, I have 
used  
1.) a Dicer knockout adenocarcinoma cell line (DLD-1) because it was of special 
interest to find out how the virus replication kinetics changes if the cells have no 
Dicer present, as Dicer is a central part of the RNAi system.  
2.) a viral protein, Npro, to deplete cells of IRF3, to suppress the IFN response and 
study the effects on SINV replication 
3.) and siRNA to deplete cells (knock down) of RHA, to assess if it acts as an 
antiviral factor, or the opposite, a viral replication factor in SINV replication. 
(Both cases have been reported previously.) RHA is also important in RNAi, as 
it is an essential factor in RISC loading. 
4.3. Results 
4.3.1. Generation and characterization of Sindbis virus 
4.3.1.1. Generation of Sindbis virus 
An overview of the SINV generation can be found on figure 4.1. The plasmid 
encoding the infectious clones SINV-TR339, TR339-GFP and TR339-mCherry were 
linearized using XhoI (Rice et al), and transcribed using Ambion’s mMessageMachine 
SP6 RNA polymerase kit (Figure 4.2A). The product mRNA (1µg) was separated on a 
native agarose gel to check for integrity (Figure 4.2B). BHK cells were transfected with 
0.5 μg mRNA using Lipofectamine 2000 in a six well plate. The transfection reagent 
was removed after four hours, and the cells were incubated until the first cytopathic 
effects (cells rounded up and detaching) were observed. AR339 strain was received as 
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viral stock, and was used to infect BHK cells in a six well plate. In both cases after 
48hpi the cell culture medium was collected, and cellular debris was removed by 
centrifugation at 3000rpm at 4°C. The virus was concentrated using one of two 
methods. Initially ultracentrifugation was used, and later concentration was performed 
using a polyethylene glycol system (PegIt) by SBI for cost effectiveness and simplicity.  
The protocol greatly simplifies virus concentration. The virus-containing medium is 
incubated overnight in a 1:5 ratio with PegIt at 4°C. This follows a centrifugation step 
using a table top centrifuge to achieve effective virus concentration. Both methods gave 
satisfactory results for virus concentration, but ultracentrifugation is more time 
consuming and there is a higher chance of contamination of the virus samples due to 
handling. PEG-It was developed by SBI to concentrate lentivirus stocks, but tests 
showed that it worked equally well with Sindbis virus.  
4.3.1.2. Detection of Sindbis virus 
SINV containing supernatant collected from BHK cells was subjected to serial 
passage through HEK293C cells to adapt the virus to efficiently replicate in a human 
cell line. It was important because high level of infection was needed in subsequent 
experiments. One-step RT-PCR, northern blot analysis, western blot analysis and 
immunocytochemistry were also used to monitor the accumulation of viral nucleic acids 
and proteins in infected cell samples for screening purposes (Figure 4.2C, Figure 4.3, 
Figure 4.4, Figure 4.5). 
Northern blotting was carried out using the following protocol. HEK293C cells 
were infected with Sindbis virus at MOI=8.0 for 30 minutes. After the incubation period 
the cells were washed with PBS twice, and the medium replaced.  The cells were 
collected at different time points post-infection, the RNA isolated and quantified with a 
Nanodrop instrument. The concentrations and the quality of samples were verified by 
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checking the intensities of the 18S and 26S RNA bands on a native agarose gel. For 
Northern blotting, 3µg from each time point was loaded onto a denaturing formaldehyde 
agarose gel, and blotted onto a nitrocellulose nylon membrane. After UV crosslinking 
the membranes were blotted using P
32
- ATP radioactive labelled virus specific probes. 
Figure 4.3 shows a positive strand specific probe labelled membrane. The probe is 
specific to the 26S subgenomic region of the genome, and detects both the subgenomic 
and full length genomes (position7568-7631). The double band on the blot represents 
the full length (49S) and the subgenomic RNA (26S). The time course shows that the 
virus has established an efficient replication by 4hpi, and the rate of replication 
increased dramatically by 8hpi.  
The accumulation of viral proteins were monitored using Western blotting (Figure 
4.4) and microscopy (Figure 4.5) (Figure 4.6) with the use of polyclonal antibody 
against the viral structural proteins. 
 GFP tagged Sindbis virus is readily detectable directly under a fluorescent 
microscope, simplifying screening, while non-tagged virus strains need to be stained 
using anti-SINV antibodies.  
59 | P a g e  
 
 
Figure 4.1 Overview of SINV generation using infectious clones. The plasmid carrying the DNA 
copy of the viral genome is linearized with a restriction endonuclease (XhoI), and the linear plasmid is 
used to transcribe mRNA. The mRNA is transfected into BHK cells, which translate the genome, and 
start producing virions. The virions are concentrated from the medium, and the biological activity of the 
stock is assessed using virus titration. The virus then is adapted to the target cell using serial passages 
until the virus reaches high enough titre, and the TCID50 (tissue culture infectious dose) is monitored.  
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Figure 4.2 Production of SINV genome using infectious clones. A.) SINV infectious clone is 
linearized using XhoI restriction endonuclease. a.) SINV-TR339 plasmid, suprecoiled b.) SINV-TR339 
plasmid, linearized with XhoI c.) SINV-TR339-GFP plasmid, supercoiled d.) SINV-TR339-GFP 
plasmid, linearized with XhoI. B.) SINV cRNA is transcribed from linearized plasmid encoding the SINV 
genome using the bacteriophage SP6 promoter. The resulting RNA was separated on a native agarose gel 
for quality check. a.) SINV-TR339 RNA product b.) SINV-TR339-GFP RNA product. C.) SINV virus 
detected in BHK cells after a passage of viruses, showing effective virus production. a.) RNA isolated 
from mock infected  BHK cells b.) RNA isolated from SINV-infected BHK cells. The virus is detected 
using one-step RT-PCR and custom SINV primers (product size 600bp). 
  
13kB 
13kB 
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Figure 4.3 Time course of SINV replication in HEK293C cells. HEK293C cells were infected 
with SINV-GFP for 30 minutes at MOI >8 and the accumulation of SINV genome monitored using 
northern blotting. The upper band shows the full-length RNA (49S), while the lower band shows the 
subgenomic RNA (26S). The lower image is of the denaturing agarose gel prior to transfer, with the 28S 
and 18S ribosomal RNA bands, to show equal loading. 
 
Figure 4.4 SINV replication over a time course of48hrs in HEK293C cell. Western blotting with 
polyclonal anti- SINV antibody shows that the concentration of SINV proteins increase over time. The 
antibody detects E2 at 60kDa, E1 at 35kDa and C (capsid) at 20kDa. 
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Figure 4.5. SINV effectively infects BHK cells, and cells die by apoptosis by 24hpi. BHK cells 
were infected and stained with anti-SINV antibody. (Blue: DAPI, green: anti-SINV antibody.) The first 
viral proteins appear at 2hpi, forming small puncta (arrows), and by 4hpi the replication centres are fully 
formed (arrows). The first burst occurs at 8hpi (as measured by one-step growth curve experiments, 
which corresponds to the literature as well), and the cells are rounded by 24hpi indicating cell death. By 
36hpi all cells are detached. 
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Figure 4.6. SINV passaged from BHK cells onto HEK293C cells replicate efficiently. SINV 
AR339 was propagated on HEK293C cells for 3 passages. Cells infected with the adapted AR339 strain 
were stained with anti-SINV antibody. (Blue: DAPI, green: anti-SINV antibody.) Virus replication is 
already well established by 4hpi, but the apparent apoptotic effects only appear around 60hpi (not shown), 
demonstrating that the dynamics of viral reproduction is different in different cell lines. 
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4.3.1.1. Titration of virus stocks 
Recent advances in batch image processing made it possible to accurately count and 
quantify cells in large number of micrographs without human interference. I have 
utilized a freely available software package, Cell Profiler and Cell Profiler Analyst, to 
count and measure SINV stained cells in dilution series, and Graphpad Prism to 
calculate the TCID50/ml of the virus stock (A. Carpenter et al. 2006; CellProfiler 
Project; T. R. Jones et al. 2009). 
The BHK cells were plated in 96 well plates and infected with SINV. Due to the low 
magnification used it was possible to use standard tissue-culture treated plates, instead 
of plating the cells onto individual cover slips. Black or white, flat bottomed plates 
provide better images of better quality, as they are designed for fluorescent microscopy. 
These plates, however, are significantly more expensive than plain tissue culture treated 
plates. The cells are infected with a dilution series of SINV stock / cell culture medium 
containing SINV, and incubated (Figure 4.8-1.). After eight hours of incubation the 
cells are fixed, stained using SINV specific polyclonal antibody and counterstained with 
DAPI. (8 hpi as was chosen because of practical reasons: viral proteins are already 
present in high abundance, and the virus has undergone only one round of infection at 
that time point.) The immunostaining steps can be automated using pipetting stations, 
reducing both the workload and the time necessary for the experiment. Using an 
inverted microscope (Zeiss Axiovert 135) at 10X magnification micrographs of 5 
randomly selected fields of views (FOVs) were taken (Figure 4.8.-2A). To avoid bias 
the FOVs were chosen using the blue (DAPI) channel. This step can also be automated 
using a motorized stage and autofocus to take images from pre-programmed areas of the 
plate, which considerably reduces the workload. The individual channels in each of the 
resulting digital image files were exported into greyscale 8bit TIFF format (Figure 4.8.-
2B). These images were analysed by Cell Profiler using a pipeline of actions that was 
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performed in the whole image set automatically (4.8.-2C). The threshold between 
background and nuclei on the blue channel images needs to be set for each batch of 
images analysed; hence high contrast images are desirable. Cell Profiler has modules 
that can perform background correction and other image processing steps should the 
quality of images require these, but ideally the image quality should be such that they 
can be omitted. Because cells can be tightly packed and their cytoplasm can be partially 
overlapping, it is sufficient and necessary to define cells as an area around the nuclei 
with a radius of the nuclei plus two pixels.  
The software first identifies cell nuclei using the blue channel, and then measures 
the integrated fluorescence value on the green channel in the area defined as cells 
(radius of the nucleus plus two pixels). This data is fed into Cell Profiler Analyst where 
the cells are scored using a machine learning algorithm which can be "trained" using the 
actual image set. The training consists of manually sorting randomly selected cells into 
positive and negative categories, and instructing the software to set up the selection 
rules. Repeating this process several times will refine these rules. The accuracy of the 
selection criteria is verified by retrieving positive and negative cells from the image sets 
and checking them manually. Once the computer is able to accurately sort cells into 
positive and negative categories, the analysis is performed on the whole image set. The 
cells are sorted into positive and negative categories, and the data is exported in a .csv 
file (Figure 4.8.-2D). Finally Microsoft Excel is used to determine the percentage of 
infected cells per dilution, and Graphpad Prism 5.0 is used to calculate the EC50/ml 
value (which is the same as TCID50/ml in case of virus infection of cells) using non-
linear regression fit. 
4.3.1.1.1. Comparison of image processing methods with plate reader results 
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The quantitation of fluorescently labelled infected cells can also be performed using 
multiwell plate readers. For this method opaque (black or white) 96 well plates are 
needed with flat and clear bottom, as these plates are optimized for fluorescent 
microscopy. BHK cells were plated and infected similarly to the previous method, 
labelled with anti-SINV antibody, and the plates were read using a FLUOstar Omega 
multiwell plate reader (BMG labtech). The integrated intensity values of the dilution 
series were used to calculate the EC50 and the TCID50/ml value with Graphpad Prism. 
This method is considerably faster and requires less manual labour, however it is costly 
in equipment and consumables, as the specialized plates and plate reader are expensive. 
The results are similar with both methods when applied to the same samples (Figure 
4.9).  
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Figure 4.8 Titration of SINV AR339 infected HEK293C cells by automated image analysis with 
Cell Profiler. 1.) A dilution series is prepared from the medium of infected cells / viral stock, and used to 
infect BHK cells. 8hpi the cells are fixed and stained for SINV using anti-SINV antibody (blue: DAPI, 
green: anti-SINV antibody.)  2.A) Images are taken of five random fields in each dilution using DAPI and 
GFP filters 2B) the blue and green channels are loaded separately onto Cell Profiler, which identifies the 
nuclei using the blue channel and determines level of fluorescence in the green channels. 2C) shows the 
processed images with the contours of the nuclei and the cytoplasm which is defined as the diameter of 
nuclei +2 pixels. 2D) Data along with the fluorescent integrated intensity of the green channel is fed into 
Cell Profiler Analyst, which can sort the positive and negative cells after training (machine learning).  
 
Figure 4.9 Comparison of one step growth curve experiments using imaging based virus 
titration and intensity measurement-based titration using multiwell plate reader. The same 
biological replicates were measured with imaging based titration and intensity measurements using 
mulitwell plate reader, and the results graphed. Both methods show the same result using the same sample 
which indicated good degree of reproducibility with either method. 
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4.3.2. Characterization of interferon response to SINV infection in 
mammalian cells 
4.3.2.1. Sindbis virus does not induce type I interferon response in the first 
24hrs after infection in HEK293C cells 
The HEK293C cell line is permissible for SINV infection, and after adaptation high 
virus titre can be achieved which was deemed crucial for finding vsRNA sequences in 
the high-throughput sequencing experiments, which was an important selection factor 
for choosing it for the high-throughput sequencing experiments.  SINV does not 
replicate well in DLD-1 cell lines, making this cell line a poor candidate for svRNA 
detection. DLD-1 cells were used for establishing the role of Dicer in viral replication 
because of the availability of Dicer -/- strain.  
As a positive control for IFN induction I have used polyI:C. PolyI:C is a synthetic 
double stranded RNA homologue, and is detected by the innate immunity as dsRNA. 
Because dsRNA is a danger signal indicating viral replication (dsRNA is a viral 
replication intermediate, and it is a pathogen associated molecular pattern, or PAMP), 
polyI:C is used widely. The detection of polyI:C leads to the stimulation of the IFN 
pathway in most cell types. Cells expressing TLR3 can be stimulated with polyI:C 
exogenously; HEK293C cells lack TLR3 and polyI:C has to be transfected into cells. 
Cell culture medium (supernatant) from HEK293C cells were collected 24hrs after 
transfection with a concentration series of polyI:C, and from cells inoculated with two 
different SINV strains (SINV AR339, TR339) in a time course experiment. After 
heat/UV inactivation of SINV present in the supernatant, it was added to DY8 cells for 
8hrs, the cells were lysed and luciferase assays were carried out. Heat inactivation 
renders the virus incapable of replication, and it would not be able to infect the DY8 
cells. It is important that the assay detects the IFNs present in the supernatant, and not 
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the IFN response of activated DY8 cells. Viral proteins and RNA were still present in 
the heat inactivated supernatant added to the DY8 cells.  
DY8 cells are stably transfected with a luciferase gene under the control of three 
IFN-β promoters (ISREs), which act as a reporter gene for IFR-stimulation. Results 
obtained with the virus infected samples showed that while polyI:C effectively up 
regulates the expression of type I IFNs in a dose dependent manner after 24hrs, none of 
the SINV strains used triggered the type I IFN response at any time points (Figure 
4.9A-B).   
These results show that the production of type I IFNs is suppressed in SINV 
infected HEK293C cells at the early stages of the virus infection, and these findings are 
in line with previous studies (Frolov et al. 2012). 
4.3.2.2. Sindbis virus induces apoptosis at 60hpi in HEK293C cells 
SINV infection has been reported to trigger apoptosis in most mammalian cell lines 
through both extrinsic and intrinsic apoptotic pathways. One major apoptotic pathway 
activated by SINV is the caspase pathway (Nava et al. 1998). BHK cells show 
cytopathic effects (rounding and detachment) by 24, and by 32hpi most cell are 
detached. HEK293C cells show similar reaction after 3-4 days. Using the Promega 
Caspase-Glow 3/7 assay Caspase-dependent apoptosis was detected by 72hpi in 
HEK293C cells, these findings are in line with the observation that HEK293C cells will 
undergo apoptosis days later than BHK cells (Figure 4.10). These data shows that at 
early stages of SINV infection the apoptotic machinery is not activated, and degradation 
of RNA by apoptotic processes would not occur at 4 and 6hpi. Non-specific RNA 
degradation products would interfere with the high throughput sequencing of Dicer-
generated sRNA population of infected cells. This was one of the main reasons to 
choose the 4 and 6hpi time points for high-throughput sequencing.  
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It is interesting to note the differences between two transgenic SINV strains. The 
SINV TR339 strain generated higher Caspase3/7 activity than the SINV TR339- 
mCherry strain. The mCherry tag interferes with the assembly of the virus capsid. The 
SINV TR339 and SINV TR339-GFP strains have similar characteristics as the GFP tag 
is not fused to any viral protein (data not shown). We have observed that over several 
passages the the mCherry tag is lost in the mCherry-TR339 strain, which also points to 
it being detrimental for viral replication. 
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Figure 4.9 Type I interferons are induced in HEK293C cells by polyI:C, but not by SINV 
AR339 or TR339. A.) Double stranded RNA (polyI:C) effectively induces type I IFN expression in 
HEK293C in a dose dependent manner. Cells were transfected with polyI:C using lipofectamine and the 
IFN activity in the supernatant was measured with luciferase assay. The line above bars indicate groups 
which were not significantly different (Student's two tailed t-test) B.) Sindbis virus trains AR339 and 
TR339 do not activate IFN production in HEK293C cells. HEK293C cells were infected with SINV 
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AR339 and TR339 in a time-course experiment, and the IFN activity of supernatant measured by 
luciferase assay. 
 
Figure 4.10 Sindbis virus triggers apoptosis in HEK293C cells in a 72hr period. HEK293C cells 
were infected with SINV-TR339 and SINV-TR339-mCherry strains, and collected at 8, 24, 32, 48 and 
52hpi. Caspase3/7 activity was measured using the Promega Caspase Glow3/7 assay, and the signal from 
virus infected samples was normalized to the control and plotted against time. 
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4.3.3. Host factors involved in SINV replication 
4.3.3.1. Dicer -/- cells are more permissive to SINV replication than the wild 
type control 
Several cellular factors have been identified as potentially important in virus 
replication with a wide range of functions: signal transduction factors in innate 
immunity, cell cycle regulation, apoptosis, cell differentiation, as viral replication 
factors, etc. Because of the focus of this study, components of the RNAi system were of 
special interest. It was an important question to investigate if Dicer, one of the main 
effector proteins of RNAi, has any effect on SINV replication. Cells depleted of Dicer 
have been reported to be more permissive to viral replication, producing viruses in a 
higher yield than wild-type cells (Triboulet et al. 2007, p.-1). Dicer was also shown to 
be down regulated by several cellular stress signals and type I IFNs, demonstrating a 
connection between innate immunity and RNAi (Wiesen & Tomasi 2009). It was, 
therefore, a great interest to find out if Dicer has an antiviral role in mammals.  
4.3.3.1.1. DLD-1 Dicer -/- cells have decreased miRNA expression profile 
The DLD-1 colon cancer cell line which has a considerably reduced Dicer activity 
due to a mutation induced in exon 5 of the Dicer gene. Complete Dicer knockout 
usually confers a lethal phenotype in both cell lines and animals; the DLD-1 Dicer -/- 
cell line has a very low Dicer activity, which is under the detection limit of northern 
blotting (Figure 4.11).  
4.3.3.1.2. DLD-1 Dicer -/- cells show increased viral RNA and protein accumulation 
A time-course experiment showed between two and three fold increase of viral RNA 
accumulating in Dicer KO cells compared to their wild-type counterparts (Figure 4.12) 
using northern blotting on total RNA from a time-course experiment. The densitometric 
analysis of SINV-specific northern blot signals confirmed this result. Similar trend was 
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seen using microscopy: Dicer knockout cells were more permissible to virus infection in 
time course experiments. Using the same virus stock in control and Dicer -/- cell, twice 
as many Dicer -/- cells were infected with SINV virus over a 24 hour period (Figure 
4.13).  
4.3.3.1.3. Effective SINV replication is hindered in DLD-1 cells 
To assess the dynamics of virus replication one-step growth curve experiments were 
performed on DLD-1 wt and Dicer -/- cell lines infected with SINV. The level of 
infectivity of the media collected from the two cell lines did not differ from each other 
significantly, indicating that the cells produced similar quantities of virions (Figure 
4.14). This apparent discrepancy between these results and the results of previous 
experiments is not surprising looking at the graph of the one-step growth curve 
experiment. The curve is repressed, showing limited virus release; compared to other 
cell lines, the burst size is very small. (Burst size is the difference in TCID50/ml values 
between the eclipse phase, the first part of the virus replication, and the plateau phase, 
release of virus particles.) This result points to the possibility that while SINV can infect 
and replicate in DLD-1 cells, virus assembly and/or release is severely impeded in this 
cell line, which can indicate lack of essential cellular viral replication factors, or an 
effective immune response on behalf of the cell. The northern blotting and the 
microscopy results, however, suggest that SINV replicate better in the absence of Dicer.  
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Figure 4.11 DLD-1 Dicer -/- cells have no detectable Dicer activity and do not express 
detectable amount of miRNAs. A SINV-infection time-course was prepared with both DLD-1 WT and 
Dicer -/- cell lines. The Northern blot hybridization of miR-21 specific primer probe shows that the level 
of miR-21 is under the detection limit in case of Dicer -/- cell lines. U6 blot is shown for equal loading. 
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Figure 4.12 Effect of Dicer on the accumulation of SINV mRNA. A). SINV RNA accumulation in 
Dicer knockout and wild type cells over time. The Northern blotting experiment was performed using a 
positive strand specific probe. It shows higher levels of Sindbis RNA in Dicer knockout cells. Lane 1-6 
Dicer WT, lane 7-12 Dicer -/- cells. GAPDH blot is shown for equal loading. B). Quantitation of the 
northern blot demonstrates that the level of Sindbis genomic RNA is 3x as high in Dicer knockout than in 
wild type cells. (WT sample at 24hpi was used as a 100% for comparison purposes.) 
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Figure 4.13 DLD-1 Dicer knockout cell are more permissive to SINV infection. A.) DLD-1 WT and 
Dicer KO cells were infected with SINV-GFP at high MOI, and fixed at different time points. Microscope 
images were taken at random locations. (Blue: DAPI, green: anti-SINV antibody.) B.) The cells were 
counted using automated cell counting; the ratio of infected cells was plotted over time. The accumulation 
of GFP (and virus proteins) was almost two-fold in Dicer knockout cells than in wild type. By the end of 
the 24hr time course all DLD-1 Dicer Knockout cells were infected, while only 54% of wild type cells 
were positive for SINV. 
 
 
Figure 4.14 Effective SINV replication is hindered in DLD-1 cells. The one step growth curve 
shows SINV virus replicating in wild type and Dicer knockout cells. The suppressed exponential phase 
suggests that SINV virus replication is hindered in the DLD-1 cell line, as the amount of released, 
biologically active virions is very low.  
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4.3.3.2. The inhibition of IRF3 does not have an effect on SINV replication 
Interferon Regulatory Factor (IRF3) plays a key role in the type one interferon 
response (Figure 1.4), and the absence of IRF3 should completely block IFN induction, 
thus we should observe an increased viral replication. IRF3 is also essential for 
apoptosis; cells lacking IRF3 have a decreased apoptotic response. Viruses are routinely 
propagated in cells that have deficient IFN response (e.g. Vero cells), and viral IFN 
inhibitors are also used to remove IRF3 or other IFN signalling components to make 
cells more permissible to viral replication (Hopps et al. 1963). These techniques are 
used to culture exotic viruses in cell culture environment. Transgenic animals lacking 
IRF3 or TBK are hypersensitive to virus infection due to the inactivity of the IFN 
response (Menachery et al. 2010). 
Sindbis virus has been reported to suppress the interferon response early in the 
infection in many cell lines by unknown mechanism (J H Strauss and E G Strauss 2009; 
Byrnes et al. 2000; Klimstra et al. 1999; Nava et al. 1998; Ryman et al. 2007). Studies 
conducted using mice demonstrated the presence of type I interferons in the blood of the 
animals, indicating that the suppression of the interferon response is not complete and 
systemic (Nava et al. 1998; Ryman et al. 2007).  
4.3.3.2.1. HEK293C cells are expressing Npro when using transient expression system 
N
pro
, the N-terminal protease of the Pestivirus family, is a known IRF3 inhibitor (La 
Rocca et al. 2005). It induces the degradation of IRF3 in mammalian cells, and thus 
blocks the type I interferon response. I have used it to deplete cells of IRF3 and inhibit 
their type-I interferon response.  
A plasmid carrying the mCherry tagged version of this viral protein was transiently 
transfected into HEK293C cells (Figure  4.15A-B.), and the effect of the absence of 
IRF3 on Sindbis virus reproduction was determined. Because N
pro
 is toxic for the cells, 
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it was important to determine the optimal amount of plasmid that can be transfected 
without killing them, and still achieving high degree of expression in this transient 
system. The mCherry tag offers a quick and easy way to observe the level of expression 
and the efficiency of transfection. One-step RT PCR was also used to monitor N
pro
 
mRNA expression in the transfected cells (Figure 4.15A), and Western blotting made it 
possible to monitor the protein levels of N
pro
 and IRF3 (Figure 4.15B). As expected, the 
level of IRF3 decreased by the expression of N
pro
. 
4.3.3.2.2. IRF3 suppression has no effect on SINV replication in HEK293C cells 
Wild type and mCherry-N
pro
 expressing HEK293C cells were infected with SINV-
GFP, and the produced viruses were titrated using one-step growth curve experiments. 
The results show that the virus replication is not affected by N
pro
 (Figure 4.16). This 
finding suggests that Sindbis virus suppresses the type I interferon response in non-
immune cell lines, in line with my previous results. By blocking the IFN response with 
the removal of IRF3, the additional suppression did not cause synergistic effects on 
viral replication. At this stage it is difficult to determine the role of IRF3 in antiviral 
defence against SINV. The lack of effect upon IRF3 inhibition suggests that if IRF3 is a 
host factor against SINV infection, it (or other signalling molecules in the IRF3 
signalling pathway) may already be suppressed by SINV. This possibility will have to 
be explored in future research. 
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Figure 4.15 N
pro
 is present in HEK293C cells transfected with N
pro
 -mCherry plasmid. A.) 
mCherry-N
pro
 is present in transfected cells. The mCherry-N
pro
 plasmid was transfected into HEK293C 
cells, after 24rs the cells were collected, and the RNA was extracted using Trizol. One step RT-PCR was 
performed using N
pro
 primers. B.) N
pro
 mCherry suppresses IRF3 levels in HEK293C cells. HEK293C 
cells were transfected with mCherry- N
pro
 plasmid. After 24 hrs the cells were collected, washed in PBS 
and lysed with hot SDS buffer. The protein samples were ran on a 12% SDS-PAGE gel and probed with 
IRF3, N
pro
 and β-Actin antibodies. β-Actin is shown for equal loading.  
 
Figure 4.16 N
pro
 -therefore decreased levels of IRF3- has no effect on SINV replication in 
HEK293C cells. One step growth curve experiment was conducted on wild type and mCherry- N
pro
 
expressing HEK293C cells. There was no difference in virus replication between the samples.  
600bp 
65 kDa 
55 kDa 
41 kDa 
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4.3.3.3. RNA Helicase A has antiviral effects during SINV infection 
RHA is a multifunctional protein, part of the DExD/H box helicase family (along 
with Dicer and RLRs; Figure 1.2), that has diverse roles in transcription, translation, 
antiviral immunity (L. Lin et al. 2012), but also in RNA interference, as a factor 
important in RISC loading (Robb & Rana 2007a).  
RHA shown to be a dsRNA sensor in myeloid cells, and the C-terminal domain was 
shown to interact with MAVS, suggesting that RHA links into the RLR pathway (Z. 
Zhang et al. 2011, p.9).  It is an ISG and it has been shown to be phosphorilated by the 
dsRNA-binding kinase PKR, demonstrating the connection between RHA and antiviral 
immunity. (Sadler et al. 2009) It is interesting to note, however, that many virus use 
RHA as a replication factor; for example, RHA plays an essential role in the replication 
of foot-and-mouth virus (Lawrence & Rieder 2009), and it enhances influenza A virus 
replication (L. Lin et al. 2012, p.1). Our laboratory has demonstrated that RHA binds to 
N
pro
 (unpublished results), but the nature of the interaction is not yet clear. It was, 
therefore, of great interest to see what effect RHA has on SINV replication. RHA 
specific siRNA was used to deplete cells of RHA, to find out if it plays any role in the 
viral life cycle. 
4.3.3.3.1. RHA levels can be successfully decreased with RHA-specific siRNA 
HEK293C cells were depleted of RHA using RHA specific siRNA, and the knock-
down was verified after 24hrs with western blotting with an anti-DHX9 antibody 
(Figure 4.17). 
4.3.3.3.2. RHA has a negative effect on SINV replication  
One-step growth curve experiment showed that SINV replication is significantly 
higher in RHA knockdown cells (Figure 4.18). This observed effect may be the result 
of an antiviral function of RHA, but another possibility is that it is due to the role of 
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RHA in RISC loading.  RHA knock-down cells have impeded RNA interference 
response (Robb & Rana 2007a), which may help the virus replicate. Virus replication 
may be enhanced if no svRNA molecules are produced by the cell, and/or the cells are 
unable to alter their miRNA expression patterns in response to the virus infection. 
However my own findings (Chapter 6) suggest that the RNAi machinery is functional in 
RHA knockout cells, hence the observed difference in virus replication in RHA 
knockdown and wild-type cells is probably not due to suppressed RNA interference 
system. These novel results points to potential antiviral roles of RNA helicase A during 
SINV infection.  
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Figure 4.17 RHA protein levels decrease using RHA siRNA (western blot). RHA-specific siRNA 
was transfected into HeLa cells, and the cells lysed 24hrs post transfection. RHA was detected with 
Western blotting using anti-RHA antibody. 
 
Figure 4.18 RHA has a negative effect on SINV replication. One step growth curve experiment 
was conducted in both wild type and RHA knockdown HEK293C cells. After 16hpi the knockdown 
samples had significantly higher levels of virus present in the medium (student's two tailed t-test). 
 
 
  
55 kDa 
141 kDa 
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4.4. Discussion 
4.4.1. Virus Titration 
For the quantitation of viral particles produced in cells I have developed both an 
image-based titration method and a multiwell-plate reader based titration method. These 
methods offer several advantages over the traditional TCID50 and plaque assays 
currently in use. The main reason behind the development of these methods was that 
they do not require the virus to form plaques. This means they can be performed in a 
wider variety of viruses than the traditional assays would allow. The only requirement is 
the availability of specific antibodies.  
These assays also require less time, as it is not necessary to wait for visible plaque 
or cytopathic effects to develop; as soon as the viral proteins are translated, the assay 
can be employed. They are highly automatable and reduce workload considerably. 
Since the computer does the counting according to pre-set criteria, the observer bias is 
greatly decreased. Bias is always an issue with the evaluation of TCID50 assays, as they 
depend on the person's judgment conducting the study. Automated systems, depending 
on the degree of automation used and the method chosen, are cost effective as well. 
4.4.2. The relationship between Sindbis Virus and the Innate Immunity 
The interferon assay based on cells expressing ISRE-controlled luciferase gene is a 
very sensitive assay to detect type I interferons from tissue culture medium. This assay 
showed that HEK293C cells are responding to double stranded RNA with production of 
interferons, while SINV infection did not trigger IFN production. Carrying on with this 
line of the investigation, Jasmine Buck and Stephen Lewis working in our laboratory 
demonstrated that while SINV infection does not up regulate type I IFN gene 
expression, several innate immunity genes (RLRs, interferon-independent cytokines) 
are up regulated (data not shown). 
87 | P a g e  
 
Sindbis virus causes an acute infection and triggers apoptosis is most mammalian 
cell lines, while it is a persistent chronic infection in its vector. The cytopathic effects 
were clearly observable on BHK cells after 24hpi, but HEK293C cells only underwent 
apoptosis at 60-72hpi as detected by a Caspase 3/7 activation assay, demonstrating that 
virus-cell interactions are dependent on both the virus and the host cell, and can be very 
different.  
4.4.3. Cellular factors and SINV replication 
The imaging based virus quantitation protocol made it possible to monitor the 
dynamics of virus replication using one-step growth curves. The cells were infected at 
MOI>8 at the same time point, and after 30 minutes of incubation the media was 
replaced, making sure that all cells are infected at the same time. The cell culture media 
was sampled at different time points, and the amount of viral particles determined in 
each sample. This method can detect when the first virus particles are released from the 
host cells, and how big the viral load is, giving an accurate picture of viral replication 
kinetics. Comparison of these values acquired from different experimental systems help 
us understand the potential effect of any cellular factor, mutations in either the host or 
viral genome, or any given treatment have on the replication of virus. 
4.4.4. Effects of Dicer on viral replication 
Dicer is one of the key members of the RNA interference machinery, and is 
responsible for producing the small 20-24 mer RNA duplexes (miRNAs) from their 
progenitors (pre-miRNAs), which are loaded onto the RISC complex and consequently 
used to target their complementary sequences. It is also responsible for processing 
dsRNA into siRNA fragments; in this, mammalian cells greatly differ from plants and 
invertebrates which usually have more than one Dicer homologue.  
88 | P a g e  
 
DLD-1 WT and Dicer -/- cells were infected with SINV-GFP, and subjected to 
several experiments. Time course northern blotting, time-course imaging and one-step 
growth curve experiments were performed to understand the effect Dicer has on the 
virus replication. 
As the DLD-1 Dicer knockout cell line grows slower than the wild-type control, it 
needed to be seeded at a higher density (1.5X) a day prior to experiments. This ensured 
that the amount of cells in control and Dicer -/- groups were similar. First, a time-course 
of SINV infection was carried out. At different time points the cells were fixed with 4% 
PFA, and stained for SINV using a polyclonal anti-SINV antibody. With the help of 
batch image processing technology, an average of 70 000 cells/experiments were 
counted and sorted into positive and negative groups at different time points. The results 
show that infected with the same MOI<8, Dicer-/- are more permissive to virus 
infection; the virus protein translation starts earlier, and more cells are infected than in 
the control group.  
RNA from similar time course experiments was used for northern blotting as 
described previously, and probed for SINV with SINV specific radio-labelled primer 
probes. The blots show a similar trend: the accumulation of viral genome in Dicer -/- 
cells is double than in the control. The one-step growth curve experiment, however, 
showed that the dynamics of virus production is not altered in Dicer -/- cells. The curves 
of the wild type and the Dicer -/- cells were indistinguishable from each other. As 
discussed previously, the curves also show that the virus is not replicating well in this 
cell line. The curve is depressed, and indicates that despite of the production of viral 
nucleic acids, as shown by the northern blot, and viral proteins, as shown by the 
imaging experiments, very few virus particles are actually released. While the nucleic 
acid and protein accumulation testifies that the absence of Dicer does have an effect on 
89 | P a g e  
 
virus replication, this does not translate into increased biological activity. The reason for 
this is most likely the cells are mounting an effective immune response against the 
infection. 
There are several possibilities how Dicer can influence virus replication. The first 
possibility is that Dicer detects and processes virus replication intermediates into 
svRNA, and loads them onto RISC where they are used to repress the expression of the 
virus genome. This has been demonstrated in mosquitoes, the vector organisms of the 
virus. (Campbell et al. 2008) The second possibility is that the lack of Dicer changes the 
miRNA expression profile of the cell, and makes it more susceptible for virus infection; 
several microRNAs have been shown to possess antiviral capabilities (C. H. Lecellier et 
al. 2005; Muller & J. L. Imler 2007). Dicer, being a DExH/D helicase, may have 
hitherto unknown functions in the cell as well. It may have PRR functions, as it does in 
plants and invertebrates. Another possibility is that simply the lack of Dicer makes the 
cells less able to mount an effective antiviral response at the replication stage at the viral 
life cycle, due to their severely impaired cellular machinery, and decreased viability -to 
which their slower growth rate may be attributed to. 
4.4.5. The inhibition of Interferon Response Factor 3 has no effect on 
virus replication 
IRF3 is a central member of the type-I interferon response, and a very frequent 
target of viral IFN suppressors. The central role of IRF3 can be demonstrated by 
inhibiting it; the activation of IF-β transcription becomes repressed, suppressing the 
whole type-I IFN response.  
I have used a viral inhibitor of IRF3, N-terminal protease (N
pro
) from the classical 
swine fever virus family, to deplete HEK293C cells of IRF3. N
pro
 is a multifunctional 
cystein protease which has no known homologues in any other organism. By degrading 
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IRF3, it effectively blocks the IFN response, thereby aiding the viral reproduction (La 
Rocca et al. 2005; Bauhofer et al. 2007). 
There are several possible approaches for generating N
pro
 expressing cell lines. I 
have used lentiviral vectors to incorporate the mCherry- N
pro
 expressing gene into the 
cellular genome. I have also used plasmids encoding N
pro
 to create a stably expressing 
cell line, with a selection agent added to the cell culture medium. I have found that over 
time cells down regulate N
pro
 expression, regardless of the manner of delivery of the 
gene, and hence the generation of stably expressing cell lines was met with difficulties. 
For reproducible results the cells need to express N
pro
 in a dependable fashion at high 
level. Because N
pro
 encoding plasmids are easy to generate in large quantity using 
bacterial culture, it was decided to use fresh, transient transfections 24 hrs before each 
experiment. Transient transfection thus ensured that the level of N
pro
 expression was 
always the highest possible, once the optimal plasmid concentration was determined. 
Because the results from repeated experiments were conclusive and similar, the 
possibility of slight changes in transfection efficiency in different experiments did not 
present any problems.  
The ratio of successfully transfected cells was easily monitored by microscopy, as 
the mCherry tag is readily detectable in live cells, and western blotting demonstrated 
that the level of IRF3 is decreased in N
pro
 transfected cell lines, proving that the 
mCherry tag does not interfere with the function of N
pro
. 
The one-step growth curves, however, show that IRF3 (and N
pro
) has no effect on 
Sindbis virus replication.  
4.4.6. RNA Helicase A has a negative effect on SINV replication 
RNA Helicase A is a member of the DExD/H box helicase family characterized by 
the conserved motif Asp-Glu-Ala-Asp (DEAD) motif; the same family Dicer and the 
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RIG-I like receptors are members of. It has been implicated in many cellular processes, 
including transcriptional regulation, embryogenesis, cell growth, innate immunity and 
RNA interference (Fuller-Pace 2006; Sadler et al. 2009; Robb & Rana 2007b). 
Studies showed that RHA plays an essential part in RISC loading, and thus have a 
central role in RNA interference (Robb & Rana 2007b). RHA has been shown to be an 
important antiviral host factor (Fuller-Pace 2006), and also in case of certain viruses, a 
viral replication factor, including classical swine fever virus, influenza and foot and 
mouth disease (Sheng et al. 2013; Lawrence & Rieder 2009; L. Lin et al. 2012). 
One-step growth curve experiments performed on RHA-depleted and wild-type 
HEK293C and HeLa cells have shown that RHA depleted cells are significantly more 
permissible to viral replication than the wild type controls. This novel result points to 
the possibility of RHA plays an antiviral role during SINV infection. An alternative 
explanation is that by inhibiting RISC loading, it renders the RNAi machinery 
inoperable, making it possible for the virus to replicate better in these cells. Chapter 5 
and 6 will explore RNA interference in virus infected cells further, but the exact method 
of how RHA inhibits alphavirus replication needs to be examined in the future. 
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5. Detection of small viral RNA and miRNA profile changes 
in SINV infected mammalian cells 
5.1. Overview 
In this chapter I describe the use of next generation sequencing technology 
(Solexa/Illumina) to attempt to detect SINV originated vsRNA fragments, and to 
characterize the changes in the host miRNA expression profile. The chapter also 
describes the validation of sequencing data. Unexpectedly, Solexa sequencing showed 
only a very few number of potential vsRNA sequences mapping to the SINV genome, 
and further analysis suggested they were products of random degradation rather than 
Dicer products. The RNAi machinery is present in mammalian cells, and our hypothesis 
was that it would process viral replication intermediates in the cytoplasm; however, it 
does not seem to be the case. None of the detected vsRNA reads could be validated by 
northern blotting due to their extremely low abundance. The overall expression profile 
of cellular microRNAs did not change according to the bioinformatics analysis, which 
was verified by northern blotting on selected human miRNA sequences. The 
bioinformatics analysis was performed by and the results written with Dr Irina 
Mohorianu, RNA Computational Biology group at the University of East Anglia.  
5.2. Introduction 
The focus of this study is to elucidate the connection between the mammalian RNAi 
system and invading viruses. In other organisms where RNAi has been shown to be part 
of antiviral immunity, the presence of vsRNA fragments was demonstrated during virus 
infection (Carol D. 2011; Gordon & Waterhouse 2006; Z. Xie et al. 2004). While the 
mechanism can differ between plants and invertebrates, one thing is common in all 
cases: large amounts of virus-derived small RNA sequences are detected in virus 
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infected cells. If similar mechanism is active in mammalian cells we expect to see 
similar enrichment in vsRNA sequences over the course of virus infection. To date only 
one study attempted to systematically explore RNA virus and mammalian cell 
interactions using high-throughput sequencing (Parameswaran et al. 2010). We have 
adopted a similar approach using the 1.5 version of the Solexa/Illumina technology, and 
Sindbis virus, an arbovirus, as a candidate. SINV was chosen as it has been shown to 
trigger antiviral RNAi response in its vector organisms, the members of the Culex 
mosquito genus, and it has been shown not to encode RNAi suppressors in these 
organisms (Campbell et al. 2008). SINV also has very broad host specificity, making it 
easy to grow in a wide range of mammalian and insect cells. 
Another possibility of interaction between viruses and their host cells is the 
modulation of the cellular miRNA expression profile by either the host or the virus 
itself. RNA viruses (aside from retroviruses) have to date not been shown to encode 
microRNA sequences (C. H. Lecellier et al. 2005; Muller & J. L. Imler 2007; Umbach 
& B. R. Cullen 2009; Saumet & C.-H. Lecellier 2006). There are several studies in 
many different organisms describing differentially regulated microRNAs which have 
antiviral activity (or activity that enhances virus replication). We were interested to see 
which known human microRNAs are differentially regulated over the course of 
infection between 0 to 6hpi, as these microRNAs may potentially possess antiviral 
activity, and also because nsp2 of SINV inhibits transcription in the nuclei of infected 
cells by blocking RNA polymerase I and II within 4-6hpi, which prevents the 
transcriptional activation of antiviral genes (Frolov et al. 2012). 
5.3. Results 
5.3.1. Sindbis virus is efficiently replicated in HEK293C cells  
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The role of RNAi in the context of mammalian innate immunity against RNA 
viruses is not yet established.  SINV is a valuable research model of a positive stranded 
RNA virus not associated with human disease, and which can infect both mammalian 
and insect cells. SINV AR339 is an attenuated laboratory strain, first isolated from 
mosquitoes, but which has been adapted to replicate in a wide range of mammalian cells 
in culture (McKnight et al. 1996). The TR339 strain is a "reverse engineered" strain 
encoded on a DNA plasmid (infectious clone), in which most of the mutations 
responsible for the tissue culture adaptation of the virus were removed, and it is thought 
that this strains resembles best the original SINV isolate (C M Rice 1987, p.339). 
In the initial experiment, SINV was adapted by serial passaging to efficiently 
replicate in human HEK293C cells with the aim of detecting sRNAs (either miRNA or 
svRNA from virally infected cells), and in the human DLD-1 cell line to study the role 
of Dicer, a component of RNAi machinery in regulating virus infection. SINV virus was 
serially passaged through HEK293C cells to obtain high titre virus prior to infecting 
these cells with SINV at a multiplicity of infection (moi) of 8.  RNA was isolated at 
different time points (2, 4, 6, 8hpi) and virus replication was detected by Northern 
blotting with SINV specific probes. The presence of full length transcripts at 49S and 
the sub genomic transcript at 26S demonstrated efficient replication starting between 2 
and 4hpi in HEK29C cells and increasing through 8hpi (Figure 5.1A). Total RNA was 
isolated at different time points (2, 4, 6, 8hpi) and virus replication was detected by 
northern blotting with SINV specific primer probes (Figure 5.1B). The presence of full 
length transcripts (49S) and the sub genomic transcript (26S) showed efficient 
replication starting between 2 and 4hpi in HEK29C cells and increasing through 8hpi, 
demonstrating that SINV effectively and rapidly infected and replicated in HEK293C 
cells. Based on this information the time points for sRNA sequencing were chosen at 
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4hpi and 6hpi as times when there would be sufficiently high concentration of double 
stranded RNA replication intermediates as substrates for Dicer. This is also the 
approximate time frame of the switch from predominantly negative strand synthesis to 
positive strand synthesis, and the shutoff of cellular transcription processes by SINV 
(Frolov et al. 2012). Previous experiments have shown that there is no IFN production 
and no apoptotic processes that the early stages of SINV infection. After 8phi the first 
newly synthesised virions are secreted into the media and the apoptotic process initiates 
after approximately 24 or 36hpi depending on the cell line. Therefore earlier time 
points, 4 and 6hpi, were chosen to avoid RNA degradation due to apoptosis and 
potentially active parts of the cellular antiviral innate immune responses.  
5.3.2. Small RNAs from SINV infected HEK 293 cells: high-throughput 
sequencing shows viral RNA in very low abundance 
RNA was isolated from control (mock infected) and SINV infected HEK293C cells 
at 4hpi and 6hpi. cDNA libraries were generated for the small RNA (sRNA) content of 
the cells using the version 1.5 of the Illumina protocol, and sequenced using Illumina 
GA II. The sequencing yielded between 29.1M and 30.5M reads per sample (Figure 
5.2). The size class and complexity distributions for all reads for which the adapter 
sequence was identified (Figure 5.3 A1-2.) showed a preference for sequences of 
lengths 22-23nt. The reads in this size class are also characterised by a low complexity. 
Complexity is defined as the ratio of non-redundant to redundant reads, and low 
complexity characterises a low number of unique reads with high abundance (Irina 
Mohorianu et al. 2011) 
Next, the sequences were mapped to the human and SINV genomes, respectively, 
using PatMaN (Prufer et al. 2008). More than 83% of sequences mapped to the Human 
genome (HUM reads), and 0.8% sequences mapped to the SINV genome (SINV reads). 
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The size class and complexity distributions of the Hum reads (Figure 5.3 B1-2) are 
similar to the overall distributions, preserving the properties of the 22-23nt reads, while 
the SINV reads (Figure 5.3 C1-2) showed an even distribution for all size classes, 
suggesting that the SINV reads may be degradation products. This hypothesis is also 
supported by the uniformity of the complexity index (i.e. the complexity was similar for 
all size classes in the 4hpi and 6hpi samples) (Figure 5.3 C2). No conclusion was based 
on the complexity distribution for the mock sample because of the extremely low 
number of SINV reads (20 reads total) present. These findings suggested that the viral 
mapping reads were probably not Dicer1 products. In addition the ratios of vsRNA 
mapping to positive and negative strand were 4:1 at 4hpi and 20:1 at 6hpi, supporting 
what would be expected at these time points for replicating virus. (Fields virology 5th 
ed)  
To investigate the hypothesis, that the SINV reads are random degradation products, 
we analysed the distribution of expression (sum of abundances of SINV reads for all 
positions) for the whole genome (Figure 5.4B) and conducted a    analysis applied on 
the size class distribution compared to a random uniform distribution, for windows of 
length 100nt (Figure 5.4A). The purpose of identifying regions which show a 
preference for a size class is that these regions are likely to be excised in a precise 
manner through the RNAi pathway. In other words, the equal abundance of variants is 
an indication of random degradation. This analysis revealed highly significant regions 
(i.e. regions for which the size class distribution was significantly different from a 
random uniform distribution, the p Value was below 0.05 in both 4hpi and 6hpi 
samples), and regions for which the size class distribution was very similar to a random 
uniform distribution (p Value above 0.7, in both 4hpi and 6hpi samples). We attempted 
the validation of reads coming from the highly significant regions, but their abundance 
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was found to be below the detection limit using riboprobes, primer probes or LNA 
probes. 
The validation of sequencing data was done using northern blotting, which offers a 
direct and sensitive detection method of RNA sequences. Primer probes and LNA 
probes were designed to be complimentary to the most abundant viral sequences. 
Riboprobes were generated using PCR products of different lengths (300-500-1500bp) 
from different parts of the SINV genome. These PCR products were generated using 
specially designed primers which had a T7 promoter sequence on the forward primers, 
and a SP6 promoter sequence on the reverse primers added. This way the same PCR 
products could be used to generate a positive strand specific probe (using SP6) or a 
negative strand specific probe (using T7). The length of PCR product decreases 
specificity, as more than one vsRNA sequence would be detected using the same 
riboprobe. However, because of the decreased specificity the sensitivity increases, as the 
same probe would bind to many different vsRNA, amplifying the signal detected. LNA 
and primer probes are typically end-labelled with radioisotopes (ɤ-(32P) ATP), which 
means that each probe carries only one signal. Riboprobes, on the other hand, have 
multiple radioactively labelled (α-(32P) CTP) incorporated during synthesis, which 
further amplifies the signal, increasing the sensitivity of the probe. Custom, SINV-
specific LNA probes were unsuccessful to detect putative vsRNA sequences, and even 
the most sensitive method, using RNA probes, failed to detect any signal in the small 
RNA range (Figure 5.5). This suggested that the number of reads matching to the SINV 
genome is not sufficient for northern blot validations as they are below the detection 
limit. Increasing the number of mis-matches between the reads and the reference 
genome (0, 1, 2, 3 mis-matches) did not change the conclusions.  
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To better understand the interaction between the virus and the host, we computed 
the number of reads that could match to both the virus genome and the human genome. 
Only 5% of the SINV reads matched to both genomes. All of the sequences were low 
abundance and many variants were present on the SINV alignment, suggesting that the 
reads have a higher probability to be produced by the virus RNA, rather than the human 
genome. Figure 5.4B shows the lack of hotspots, which suggest the absence of specific 
cleavage of the viral genome and the lack of location specificity on the SINV genome. 
In addition, the uniform distribution of reads on both strands supports the hypothesis of 
random degradation.  
5.3.3. SINV infection does not modulate the cellular miRNA expression 
Since the majority of reads mapped to the human genome (>8M and >6M reads in 
the first two sample and in the third, respectively), we also investigated the changes 
induced by the virus infection in the cellular sRNAome. First, we identified miRNAs 
using miRCat (S. Moxon et al. 2008) and mirProf (Stocks et al. 2012); out of the 110 
predicted miRNAs, 92 (including variants) were conserved and 18 were novel. These 
formed the majority of reads mapping to the human genome. To further investigate the 
sRNAome changes, other properties of miR loci (miR precursors) were analysed. First, 
using all human miRNAs from MirBase (Griffiths-Jones et al. 2008) for which we 
could identify at least 3 reads in the samples, the distribution of signal across the 
precursors was analysed. For all miRNAs more than 90% of the signal was consistently 
concentrated on the miRNA (5p sequence) and miRNA* (3p sequence), in all three 
samples. Next the size class distribution on the precursors was analysed using a    test 
(the approach was similar to the one used for the analysis of the whole SINV genome). 
The approach was applicable since the distribution of pre-miR lengths shows little 
variation around the 100nt mark, which was used for the SINV genome. Under the 
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assumption of random uniform distribution, all of the pre-miRs had significantly 
different size class distributions, biased on 22mers. The distributions for samples 4hpi 
and 6hpi were statistically the same as for the mock sample, suggesting no influence of 
the virus infection to modulate the miRNA expression (Figure 5.6). The scatterplot on 
annotated miRNAs shows that they display little variation between the 0 hpi, 4hpi and 6 
hpi time points. Although the variation was small, we selected the miRNAs showing the 
most difference in expression as candidates. These results were confirmed by northern 
blots shown in Figure 5.7.  
Twelve highly abundant and shown to be differentially expressed microRNAs were 
chosen for northern blot verification; most of these microRNAs were implicated in 
innate immunity (see figure 5.7. and below). HEK293C cells were infected with SINV 
AR339 and SINV TR339 in biological triplicates at MOI>8; total RNA was isolated at 0, 4, 
and 6.  Three microRNAs (miR-155, -182, -496) were under detection limit, nine showed no 
changes in expression levels, corresponding to the result from sequencing.  
MicroRNA 29a has already been linked to several defences against pathogens. It is 
shown to regulate the immune response to intracellular bacterial infection through IFNγ 
modulation (F. Ma et al. 2011); also the level of miR29 increases 50-fold in A549 cells 
in response to influenza infection, which leads to IFNλ and COX2 up-regulation (Fang 
et al. 2012). In addition, miR-29 down regulates the expression of Nef protein of HIV-1, 
and it interferes with HIV-1 replication (Ahluwalia et al. 2008). miR378 was also 
shown to be targeting HIV-1 genes (Hariharan et al. 2005). mir34 was shown to be an 
important modulator of innate immune response through the regulation of IFNβ 
expression (Witwer et al. 2010). Kaposi’s sarcoma-associated herpesvirus (KSHV) and 
pseudorabies virus both encode miR10 homologues, which have an essential role in 
viral self-regulation (Y.-Q. Wu et al. 2012; Lei et al. 2010). miR19 and let7 are 
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important regulators of inflammatory responses as they upregulate NF-κB activity 
(Gantier et al. 2012). Let7 also modulates the innate immunity through the regulation of 
IFNβ expression (X. Ma et al. 2011). The miR17/92 cluster has been shown to regulate 
Epstein-Barr virus gene expression (Skalsky et al. 2012). miR196 can effectively repress 
hepatitis C virus gene expression and replication (Hou et al. 2010). miR197 targets the tumour 
suppressor protein FUS1 (L. Du et al. 2009). 
These results confirmed the conclusions from sequencing. These results show that the 
Sindbis virus infection does not change miRNA expression in HEK293 cells at a time 
when miRNAs may regulate an innate immune response or affect viral replication 
(Campbell et al. 2008). 
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Figure 5.1. Preparation of SINV infected HEK293C cells. A.) Cells were infected with SINV for 
2, 4, 6 hpi at high multiplicity of infection (MOI<8), and stained with anti-SINV antibody (Blue: DAPI 
nuclear stain, green: SINV). The immunostaining demonstrates that almost 100% of the cells are infected 
with SINV. B.) The northern blot shows the rapid accumulation of SINV RNA in HEK293C cells starting 
at 2hpi and increasing through 8 hpi. The end-labelled primer probe specific to the position7568-7631of 
the SINV genome detects full length (49S) and subgenomic (26S) (+) positive strand RNA. The 28S and 
18S RNA bands stained with ethidum bromide are displayed to demonstrate equal loading. Both images 
show the actual samples used for Solexa/ Illumina sequencing 
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Figure 5.2 sRNA library of SINV infection time course at 0, 4, and 6 hpi. Based on northern 
blotting and immunocytochemistry experiments we have chosen 4 and 6hpi time points for further 
studies. 3 µg of RNA was used to prepare the Illumina library. After PCR amplification the resulting 
cDNA was ran on a PAGE gel, and the ~100bp band (75bp adapters + 20-25bp small RNA) excised and 
sent for sequencing.  
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Figure 5.3 Size class distributions for (A1) all reads, (B1) reads mapping to the Human genome, (C1) 
reads mapping to the SINV genome. The total reads and the reads mapping to the human genome are 
enriched in 22-23 nt sequences. Sequences mapping to the SINV genome show even distribution 
suggesting random degradation. Complexity distribution for (A2) all reads, (B2) reads mapping to the 
Human genome, (C2) reads mapping to the SINV genome. Complexity of all sequences, and sequences 
mapping to the human genome show a decrease in the 22-23nt region, which indicates small RNA 
presence, while reads mapping to the SINV genome have an uniform complexity index, which also 
suggests degradation.  
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Figure 5.4 (A) variation of expression level for SINV reads. Reads mapping to the SINV genome are 
shown in relation of the full-lenght SINV genome (x axis). The size of peaks (y axis) shows the number of 
reads on that particular location; the orientation (positive or negative) shows which strand (positive or 
negative) of the SINV genome the reads map to. Black: samples from 4hpi, gray: samples from 6hpi. (B) 
Variation of p Value for a ChiSq significance test on the size class distribution compared to a random 
uniform distribution for windows of length 100 nt. The reads are mapped to the SINV genome as 
previous. Thick black line signifies the proteins encoded by the given part of the genome.  
 
Figure 5.5 SINV specific riboprobes are unable to detect vsRNA. The graph depicts a part of the 
SINV genome with the abundance of SINV reads mapped to the genome (red: 4hpi, green: 6hpi). The 
blue line underneath shows the area of which the riboprobe is complementary to. The blot shows a 
smear at the high molecular weight range. There are no distinct bands detected, and no signal found at 
the expected 21-22mer range (lower 1/4th of the blot). (A) 500 pb long riboprobe specific to the 
beginning of the SINV genome. (B) 1500bp long riboprobe mapping to the end of SINV genome. (C) miR-
29a probed membrane used as size marker for the expected 21mer ban 
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Figure 5.6 Sequencing results show human miRNA expression profiles remain unchanged 
during  early SINV infection (0, 4 and 6phi). A.) miRNA profile changes in 0hpi sample vs 4 hpi 
sample. B.) miRNA profile changes in 4hpi sample vs 6 hpi sample. Scatter plots of miRNA expression 
levels indicate no significant change in expression in HEK293 cells. On both x and y axis we represent 
the normalised expression levels of the miRNAs at a given time point in log2 scale. MicroRNAs chosen 
for northern blot validation are shown on the plot. 
 
Figure 5.7 Northern blots confirm that Human miRNA expression profiles remain unchanged 
during early SINV infection (0, 4 and 6phi). Northern blot validation of candidate miRNAs in SINV 
AR339 and infectious clone TR339 also support the hypothesis of no change in expression. Twelve 
microRNAs (miR10, miR19, miR29a, miR34, etc) were chosen for validation based on the change in 
their expression profile according to the sequencing data. The northern blot validation was conducted in 
biological triplicates. Three microRNAs were under the detection limit (miR155, miR182, miR-496), the 
rest showed no change in expression between the 0-6hpi period. The equal loading is shown by U6. 
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5.4. Discussion 
This study investigated whether there is a role for RNAi during SINV infection of 
mammalian cells in the light of the well-established role of RNAi in SINV infection in 
insect vectors (Myles et al. 2009; Campbell et al. 2008; Saleh et al. 2009). To date 
several modes of action of RNAi as response to viral infection have been proposed: 1) 
RNAi produces svRNAs that can target the generating transcript reducing virus 
genome, (2) the viral genome encodes miRNA-like regions that are processed by RNAi 
into miRNAs which can in turn target the genes of the host, (3) the host genome 
encodes miRNAs which can modulate viral replication through RNAi and (4) viral 
infection can influence the expression of cellular miRNAs.  The effect of RNAi can 
therefore be antiviral (as in the cases (1) and (3)) or beneficial to the virus (as in (2) and 
(4)) (Saumet & C.-H. Lecellier 2006).   
An example of the antiviral effect of the RNAi machinery which illustrates the first 
mode of action is the systemic RNAi response against SINV in Drosophila. (Saleh et al. 
2009) The second mode of action is illustrated by the herpes virus family and other 
large DNA viruses which encode miRNAs that target cellular innate and acquired 
immunity factors (A Gupta et al. 2006); for example, miRNA encoded by EBV targets 
the pro-apoptotic factor PUMA, microRNA encoded by KSHV down regulates MyD88, 
and HCMV encode miRNAs that inhibit RANTES expression (Choy et al. 2008; Bryan 
R Cullen 2013; Y. Kim et al. 2012). The third mode of action is illustrated by Hepatitis 
C Virus, for which the liver-specific miR-122 has been shown to have a stimulating 
effect on viral replication (Jopling et al. 2005). EBV infection is an example of the 
fourth mode of action (viral infection modulates cellular miRNAs expression). EBV 
strongly induces miR155 in B cells to promote cell transformation (Gatto et al. 2008).   
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 Therefore it was of interest if SINV infection of mammalian cells generated small 
RNAs to target the SINV genome, if SINV provides viral miRNA, or if the virus 
infection changes cellular miRNAs profiles during virus infection.  
In this context, we studied sRNAs during SINV infection of mammalian cells to 
understand in which of these categories it is classified. Sequencing showed that there 
were no svRNAs in the 20-25nt range which could indicate the processing of the 
dsRNA virus replication intermediate by the RNAi machinery. This would suggest that 
there is no self targeting of viral RNA. This is in contrast to SINV infection in mosquito 
cells where SINV is a substrate for RNAi as SINV vsRNAs were readily detected and 
were shown to prevent viral spread between cells (Saleh et al. 2009). In mosquitos 
variations in levels of Ago2, DICER2 and other components of RISC were observed 
during virus infection, indicating that the virus can modulate the RNAi system. Our 
results support this finding also for mammalian cells where the lack of Dicer promotes 
viral replication, indicating a role for Dicer in sensing SINV infection. What this role 
may be is unclear.  In Shapiro et al study the incorporation of a pri-miRNA into SINV 
led to the generation of a Dicer dependent mature miRNA (Shapiro et al. 2010) 
demonstrating the Dicer recognition during cytoplasmic replication of an engineered 
SINV.  
In addition, the lack of 20-25 nt svRNAs indicated that there are no viral miRNAs in 
the genome that would affect gene expression in either host or virus. This finding is in 
line with other RNA viruses, where viral miRNAs have never been described, although 
they are well documented in DNA viruses, such as herpes viruses and adenoviruses 
(Gottwein & Bryan R. Cullen 2008). 
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The sequencing data showed that human miRNAs were not differentially expressed 
in SINV virus infected cells at the early stages of virus infection. This was confirmed by 
northern blot of nine of the most abundant miRNAs being unchanged over 6 hpi. 
However, this mode of action has been associated with some RNA viruses, for example 
the picornavirus enterovirus 71 (EV71) activates transcription of miR141, which in turn 
suppresses translation of the cap-binding protein eIF4E in order to inhibit cap dependent 
translation (B.-C. Ho et al. 2011). It has also been proposed that during infection with 
HIV-1, the expression of several micro RNAs is induced (Triboulet et al. 2007). 
Although SINV infection did not up-regulate host miRNAs, it does not preclude pre-
existing cellular miRNAs influencing SINV replication, as in the case of the RNA virus 
HCV where the liver specific miR 122 stimulates viral translation (Henke et al. 2008). 
It has been shown that the SINV itself does not activate interferon at early time 
points in non-immune cells (Burke et al. 2009), but many other interferon sensitive 
genes (ISGs) have been shown to be induced within 4-6 hpi, dependant on PKR and 
MDA5. These results indicate that for SINV infection of mammalian cells a more 
effective control may be the innate immunity (Dhanushkodi et al. 2011).   
  
111 | P a g e  
 
6. Suppressors of RNAi 
6.1. Overview 
In the last chapter, I have shown that SINV infection of HEK 293 C cells does not 
lead to the production of small viral RNAs and does not modulate the expression of host 
miRNAs.  SINV, as all RNA viruses, generates a double stranded intermediate, but it is 
not recognised by RNAi. Why should this be the case, if we consider the following 
available evidence:  Firstly, exogenously added siRNAs have been shown to work 
efficiently to silence genes when added to human cells, demonstrating the presence of 
intact RNAi machinery in humans.  Secondly, it is well known that gene expression is 
modulated by miRNAs in mammalian cells during development and tissue 
differentiation (Goljanek-Whysall et al. 2012). Thirdly, human cells express a single 
Dicer, which is responsible for production of both siRNAs and miRNAs, and human 
cells contain Ago2 and the components of RISC. Despite of these reasons, my results 
demonstrate that RNAi does not act as an antiviral defence in human cells, unlike plants 
and invertebrates. In this chapter, I investigated possible reasons for this.    
I have set up a gene silencing assay to measure the activity of the siRNA pathway in 
cells. The assay involves using siRNA against a housekeeping gene, GAPDH, followed 
by northern blot to check for RNA knockdown in HEK293C. 
After optimising the knockdown of GAPDH RNA, using different transfection 
reagents and times after transfection of siRNAs, I used this assay to look for cellular 
and viral molecules that may be inhibitors of RNAi. These included RHA, which I 
previously showed inhibits viral replication (Chapter 4), and with SINV infection, or 
transfection with synthetic dsRNA (poly IC), and also cellular stress induced by sodium 
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arsenate. I have primed the cells with interferon, and finally I have used a viral inhibitor 
of the interferon pathway.  
 
RNA helicase A has been shown to be involved in the RNAi pathway. A high 
profile report in the literature demonstrated that RHA knockdown can block the RNAi 
pathway, and showed RHA is important in RISC loading (Robb & Rana 2007b). In their 
study, gene expression knockdown using siRNA and shRNA against GFP in GFP-
expressing HeLA cells was inhibited when RHA was depleted. As I have previously 
shown in Chapter 4, RHA is an important host factor in SINV replication, it was 
therefore reasonable to predict that there may be interaction between RHA and SINV 
through the RNAi pathway. When RHA is knocked down, SINV replication increased, 
suggesting that RHA modulation of RNAi may be an anti-viral defence. As cited in 
Chapter 4 discussion, RHA is an important host factor in the replication of several 
viruses (Q. S. He et al. 2008; Ranji & Boris-Lawrie 2010). In another study it was 
shown that there is an antiviral response directed by PKR phosphorylation of the RNA 
helicase A (Sadler et al. 2009). 
SINV has been shown to induce stress granules after infection of mammalian cells 
(Venticinque & Meruelo 2010). Stress granules or P bodies play an important role in the 
generation of miRNAs, as they contain Dicer, RISC, Ago and contain translationally 
silenced mRNA (Beckham & Parker 2008; Paul Anderson & Kedersha 2008).   
For these reasons I investigated whether cellular stress in general affected RNAi by 
generating stress in control cells by addition of sodium arsenate. In other experiments I 
primed cells with type I interferon to look at the effects on RNAi. In addition I 
investigated the effects of SINV infection and polyI:C on RNAi.   
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Viral suppressors of RNAi are also a well-documented mechanism of evasion of the 
innate cellular defence.  There are several examples: NS1 protein of influenza virus (de 
Vries JGV 2009, de Vries 2008, Int J biochem and cell bio), Vaccinia virus E3L, HCV 
core protein, PFV-1 Tas and the Ebola vp35 protein (Fabozzzi et al J Virol 85 2512-
2523 2011, Haasnoot et al Plos pathogen 3 e86 2007).  Viral suppressors of RNAi can 
bind to host RNAi molecules or sequester some components, and most of these proteins 
have also been shown to inhibit the interferon signal transduction pathway.  For these 
reasons I used a known viral inhibitor of the interferon pathway to investigate whether it 
also blocked the RNAi pathway in human cells.  The N-terminal protease N
pro
 from the 
pestivirus classical swine fever virus has been shown in our lab to degrade the 
transcripion factor IRF3, a central regulator of interferon synthesis (LA Rocca et al 
2005).  My work investigated if there was also a role for N
pro
 in the suppression of 
RNAi.    
6.3. Results 
6.3.1. Development of an RNAi functional assay 
To assess the functionality of the siRNA pathway of the RNA interference system, a 
knockdown assay was developed. siRNA against a housekeeping gene (GAPDH) was 
transfected into HEK293C cells (both treated and control), and the effectiveness of the 
knockdown was assayed by monitoring the amount of GAPDH mRNA either by limited 
cycle RT-PCR or northern blotting. Should a treatment suppress the RNAi system, the 
assay will show GAPDH mRNA present in the treatment samples, as the effects of the 
transfected siRNA will be diminished. This is a semi-quantitative, but direct assay 
which gives an accurate picture of the quality of GAPDH mRNA present in the sample. 
Using two housekeeping genes instead of one would make it even more robust. 
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At first, limited cycle RT-PCR was chosen for its simplicity and speed (Figure 6.1). 
Further investigations showed that this method did not have the necessary accuracy 
(Figure 6.8). For this reason I have used northern blotting for this study, as this 
sensitive method allows for direct measurement of the amount of RNA present in the 
sample. 
The RNAi assay was optimized by choosing JetPrime as the most effective 
transfection reagent. A concentration-series showed that 50nM final concentration if 
siRNA leads to effective knock-down in HEK293C cells. The efficiency of transfection 
was demonstrated using siGlow, a fluorescently tagged siRNA: 100% of the cells were 
transfected under these conditions (Figure 6.2, Figure 6.3). A time-course experiment 
showed that by 6 hrs post transfection the knockdown effect is total (Figure 6.4).  
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Figure 6.1. Limited cycle RT-PCR shows significantly lower GAPDH mRNA levels in GAPDH 
siRNA-treated cells. The knockdown experiment was conducted as described, and a limited cycle RT-
PCR experiment carried out. The results show effective knockdown of GAPDH mRNA after 24hr using 
siRNA with 50nM final concentration. a: control cells, b: mock-treated cells, c: non-targeting siRNA 
treated cells, d: GAPDH siRNA treated cells. 
 
Figure 6.2 JetPrime is more efficient transfection reagent than Dharmafect 4.0 at knockdown 
of GAPDH mRNA. The efficiency of GAPDH siRNA transfection was tested using two different 
transfection reagents using the manufacturers’ recommendations. The RNA was isolated from cells using 
Trizol, separated on a formaldehyde gel and blotted on a nitrocellulose membrane. The membrane was 
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hybridized with radioactive-labelled primer probes against GAPDH and 18S RNA (loading control). The 
results show that under these circumstances JetPrime achieved 100% knockdown on GAPDH using 
siRNA at 50nM final concentration, and that there was a visible GAPDH signal when using 100nM 
siRNA with Dharmafect 4.0 transfection reagent. a: control cells, b: mock treated cells, c: non-targeting 
siRNA treated cells, d: GAPDH siRNA 10nM final concentration, e: GAPDH siRNA 50nM final 
concentration, f: GAPDH siRNA 100nM final concentration. 18S RNA blot is shown for equal loading. 
. 
 
Figure 6.3 JetPrime effectively transfects 100% of the cells. Fluorescently labelled siGlow siRNA 
was used to monitor the effectiveness of transfection. 100% of the cells are transfected under the 
experimental conditions 
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Figure 6.4. GAPDH siRNA effectively knocks down the level of GAPDH mRNA by 4hrs post-
transfection. GAPDH siRNA was transfected into HEK293C cells and the RNA isolated, separated on 
formaldehyde gel and blotted on nitrocellulose membrane. The membrane was hybridized with 
radioactive-labelled primer probes against GAPDH. The Northern blot of the time course-series shows 
that the knockdown effect is total and persistent over 24hrs. The blot is a representative of several 
repeated experiments. 18S RNA blot is shown for equal loading. 
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6.3.2. The Effect of RHA on the siRNA pathway 
Previous study (Robb & Rana 2007b) reported that RHA depleted cells have a 
compromised RNAi response using a similar assay. The study used HeLa cells stably 
expressing GFP. RHA was depleted using RHA specific siRNA, and 24hrs after 
transfection siRNA or shRNA targeting GFP was transfected into the cells. In the RHA 
depleted cells the level of GFP mRNA was equal to the control levels (control was no 
GFP-specific siRNA/shRNA treated HeLa-GFP cells) indicating that the siRNA 
pathway did not function. Ago2 specific siRNA was used as a positive control.  
Since the study found that RHA depletion makes siRNA mediated RNA interference 
inoperable, RHA had the potential to be used as a positive control for my assay. 
However, when I repeated the GAPDH knockdown assay using HEK293C cells that 
were depleted of RHA using RHA specific siRNA, I found that their RNAi response 
does not differ from the control samples. The RNAi response was functional, and no 
difference was detected from the control group. The assay was repeated using RHA 
depleted HeLa cells, which the original study used, but the results were the same 
(Figure 6.5). RHA did not suppress siRNA mediated RNA interference in this system.  
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Figure 6.5 RHA knockdown does not have any effects on RNA interference. GAPDH 
knockdown assay in RHA depleted HeLa cells shows no suppression of RNAi; however dsRNA 
homologue (polyI:C) shows similar suppression as in HEK293C cells. The blot is a representative of 
several repeated experiments. a: control cells, b: mock treated cells, c: non-targeting siRNA treated cells, 
d: GAPDH siRNA treated cells, e: polyI:C treated cells, f: polyI:C/GAPDH siRNA treated cells. 18S 
RNA blot is shown for equal loading. 
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6.3.3. The Effect of Viral Infection, Double Stranded RNA, Interferon and 
Cellular Stress on RNAi 
SINV has been shown to induce stress granules after infection of mammalian cells 
(Venticinque & Meruelo 2010). Translational regulation of gene expression offers the 
cells a required plasticity to react sudden changes, like different cellular stress signals 
(changes in pH, salinity, temperature, infection, etc.). Cytoplasmic granules (stress 
granules, processing bodies and neuronal granules) have shown to play important roles 
in posttranscriptional gene regulation. They contain mRNA, scaffold proteins, 
ribosomal subunits, translation factors, helicases, and more importantly, members of the 
RNAi and RNA decay machinery. Because of the proteins they contain, they are 
responsible for determining the localization, the stability and the translation of mRNA.  
Stress signals will trigger a stress-response from eukaryotic cells, which leads to 
translation shutdown for the majority of proteins, and selective translational up 
regulation of stress related proteins, for example, chaperones (Harding et al. 2000). One 
of the major routes of stress response is through the phosphorylation of eukaryotic 
initiation factor 2 alpha (eIF2α). This effectively enacts a global protein synthesis 
shutdown through the blocking of CAP dependent translation, and up-regulates stress 
response gene expression, which is generally Internal Ribosome Entry Site (IRES)-
regulated, and can be translated independently from CAP dependent translation 
mechanisms (Holcik & Sonenberg 2005). Many different stress signals can lead to 
eIF2α phosphorylation through different cellular sensors. These stress signals range 
from UV light, arsenate stress to viral dsRNA-activated PKR. The phosphorylation of 
eIF2α will lead to stress response, which either helps the cells to adopt the stress, clear 
the virus, or leads to ER mediated apoptosis. The translational shutdown leads to the 
accumulation of stress granules (SG), which holds the stalled mRNA-protein complexes 
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until they are either degraded in processing bodies (PB), or their translation is 
reinitialized. SGs are thought to be intermediate compartments for storage and 
remodelling of mRNPs. The fate of mRNA stored in SGs can either be reinitiation of 
translation in polysomes, or degradation in PBs (P. Anderson 2006). Studies by Nover 
et al. (1983) found that SGs forming in response to heat shock include the mRNA 
encoding most cellular proteins, but exclude the mRNA encoding for heat shock 
proteins; this phenomenon has been described by others as well. Both SG and PB are 
structures which are in dynamic equilibrium with the polysomes, the sites of translation. 
Both types of mRNP complexes contain multiple proteins, and some of them are 
common in both. These include Ago2 and other RISC components, which are required 
to be present in metazoan PBs. What they differ in is their roles: SGs mainly contain 
components of translation initiation, whereas PBs contain components for mRNA 
decay. Both can be taken as collectors of un-translated mRNA molecules that exceed 
the capacity of the translation and decay machinery, to hold them until further 
processing. They were also shown to be interacting with each other, raising the 
possibility of mRNA exchange between different mRNP granules.  
A previous study showed that certain cellular stress signals down regulate the 
amount of Dicer present in cells, but the study did not assess the functionality of the 
RNAi system. The GAPDH siRNA knockdown assay is a functional assay, and it was 
used to examine how the function of siRNA mediated RNAi changes to different stress 
signals. Cells were treated with IFN-β, polyI:C, SINV (Figure 6.6) and arsenate. 
Arsenate had no effect; Interferon-β surprisingly did not affect the levels of GAPDH 
mRNA, but both polyI:C and SINV, however, did. Both treatments, that worked, are 
virus infection related; one is a dsRNA homologue, the other is an actual virus. (While 
the polyI:C results have been repeated in many different cell lines with consistent 
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results, the SINV-mediated RNAi suppression is a preliminary result, and should be 
treated as such.) 
There are two hypotheses why polyI:C suppresses the siRNA-mediated RNAi 
response. The first is that the effect is non-specific: the large amount of long dsRNA 
present in the cytosol simply saturates Dicer, and renders it incapable to load the 
transfected GAPDH siRNA onto the RISC complex. The second hypothesis is that this 
is a result of a specific crosstalk between cellular signalling pathways of the innate 
immunity and the RNAi system.  
Using the Dicer knockout colon cancer cell line DLD-1, it was possible to test these 
hypotheses. If the suppression is due to Dicer saturation, then all Argonauts within the 
RISC complexes would be flooded with short polyI:C duplexes, produced by Dicer, 
outcompeting any other short RNA present during RISC loading. In this case the 
GAPDH siRNA would be ineffectual as it would not be loaded onto RISC. In Dicer -/- 
cells, however, polyI:C is not processed into short fragments, and would not hinder the 
loading of GAPDH siRNA onto the RISC complexes. Therefore it should be possible to 
induce suppression of GAPDH mRNA using siRNA in Dicer -/- cells cotransfected with 
polyI:C.  
Northen blot analysis of the experiment indicates that the first hypothesis is not true; 
the observed RNAi suppression may, therefore, be the result of crosstalk between the 
RNAi system and the innate immunity (Figure 6.7). We can observe the same pattern 
as with the previous blots: both wild-type and knockout cells show GAPDH 
suppression, while polyI:C abates the effects of siRNA in both cases. The analysis of 
the band intensities shows that in the wild-type cells, where both polyI:C and GAPDH  
were transfected, the knockdown effect decreases by 28% compared to the cells 
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transfected with GAPDH siRNA only. In the Dicer    -/- cells cotransfected with both 
polyI:C and GAPDH siRNA, the decrease of the knockdown effect is 100% compared 
to the cells transfected with GAPDH siRNA only. Clearly the lack of Dicer activity 
increases the efficiency of polyI:C induced RNAi suppression, which might indicate 
that the inducing molecule is long dsRNA (as Dicer processes the long polyI:C chains 
into short fragments).  
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Figure 6.6 Double stranded RNA and SINV infection but not cellular stress and interferon can 
suppress RNA interference. (A) GAPDH knockdown assay was performed on cells subjected to 
different kinds of cellular stresses. a: mock treated cells, b: non-targeting siRNA treated cells, c: GAPDH 
siRNA treated cells. Double stranded RNA homologues (polyI:C) the RNAi machinery, demonstrated by 
the decreased efficiency of GAPDH siRNA. SINV infection shows a slight suppression, which needs to 
be investigated in the future. 18S RNA blot is shown for equal loading. (B) Densitometric analysis of the 
Northern blots. type I IFN treatment did not affect RNAi activity, but 43% of the control level GAPDH 
mRNA expression was  restored in SINV infected, GAPDH siRNA treated samples. 
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Figure 6.7 Suppression of RNAi in polyI:C treated cells is not due to saturation of Dicer with 
dsRNA. A.) The GAPDH knockdown assay was repeated using DLD-1 Dicer wild-type and KO cells, 
and the results are similar to the previous experiments. a: control cells, b: mock treated cells, c: non-
targeting siRNA treated cells, d: GAPDH siRNA treated cells, e: polyI:C treated cells, f: 
polyI:C/GAPDH siRNA treated cells. The blots show strong GAPDH signal in the polyI:C-GAPDH 
siRNA cotransfected samples, while almost no signal in the GAPDH siRNA treated samples. 18S RNA 
blot is shown for equal loading. B.) densitometric analysis of the Northern blot. The graphs shows similar 
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trends on both Dicer -/- and WT cells, namely the restoration of GAPDH mRNA signal in polyI:C, 
GAPDH siRNA co-transfected cells.  
6.3.4. The Effect of Npro on RNAi 
N
pro
 is the N-terminal protease of the Classical Swine Fever Virus (CSFV) of the 
Pestivirus family. This is a unique cysteine protease with no homologues in any other 
organism. It is a multifunctional viral protein that is responsible, among other things, for 
the autocatalytic cleavage of the virus polyprotein, and more importantly, the 
degradation of interferon response factor (IRF3). This renders the interferon system 
inoperable, facilitating virus replication (Bauhofer et al. 2007). N
pro
 also inhibits the 
transcription of IRF3 (La Rocca et al. 2005), demonstrating that the same host protein 
can be targeted by the virus at multiple levels. It has been shown to bind to IκBα and 
HAX-1, important regulators of apoptosis and immune response (Doceul et al. 2008; 
Johns et al. 2010). 
Our laboratory demonstrated that N
pro
 binds to RNA Helicase A (RHA), and that it 
colocalizes with RHA in ribonuclear particles (unpublished results). RHA was shown to 
play an important role in RISC loading by other studies: RHA knockout HeLa cells had 
been reported to possess impeded RNAi response (Robb & Rana 2007b). It was our 
hypothesis that N
pro
 might be able to suppress the RNAi system by binding RHA. 
Preparing cell lines that constantly and consistently express N
pro
 was proven 
difficult. After several approaches, I decided to use transiently expressing cell lines in 
all experiments, as N
pro
 expression diminished over time in every stably expressing cell 
lines created. This effect was observed regardless of the method N
pro
 was introduced 
(using stably expressing plasmids with selection agent or lentiviral vectors). N
pro
 is a 
cytotoxic protein and cells adapted to it by down-regulating its expression; this 
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phenomenon necessitated using freshly transfected transiently expressing cells. Plasmid 
encoding mCherry- N
pro
 was transfected 24hrs prior to the experiment to ensure strong 
expression of the protein, and the level of transfection was monitored using fluorescent 
microscopy. Fresh transfection before each experiment ensured a high, uniform 
expression of the viral protein (see Chapter 4). 
This was the first series of knockdown assays performed, and at first I have used 
limited cycle RT-PCR to evaluate the results. The GAPDH assay was performed as 
described, and RT-PCR reactions were performed on 1 µg of the isolated total RNA 
using GAPDH, N
pro
 and β-Actin primers (see Methods). After separating the products 
on an agarose gel, there was a faint band present in the GAPDH siRNA treated N
pro
 
expressing sample in all the replicate experiments, indicating the presence of GAPDH 
mRNA. This preliminary result indicated that N
pro
 might suppress the RNAi system 
(Figure 6.8). 
  
128 | P a g e  
 
 
Figure 6.8 Preliminary results using limited cycle RT-PCR shows that in HEK293C cells 
expressing N
pro
 RNAi is suppressed. Control cells and N
pro
 expressing cells were used in a GAPDH 
knockdown assay to assert if N
pro
 effects RNAi. The RNA was analyzed using limited cycle RT-PCR. 
The PCR products were separated on an agarose gel. a a: control cells, b: mock treated cells, c: non-
targeting siRNA treated cells, d: GAPDH siRNA treated cells.  There was a stronger GAPDH band 
present in N
pro
 knockdown samples suggesting that N
pro
 suppresses RNAi. Actin RT-PCR is shown for 
equal loading. 
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The experiment was repeated using a much more accurate northern blotting 
technique to detect the mRNA signals, and in this system the band in the siRNA treated 
sample was not detectable (Figure 6.9). As northern blotting detects the RNA directly 
without reverse transcription or amplification steps, this is the accepted definite result. 
This convinced me to abandon the RT-PCR method, and switch to northern blotting. 
Since N
pro
 is generally present in the whole cytosol and only translocates to RNP 
particles when the cells undergo cellular stress, or subjected to polyI:C, a double-
stranded RNA homologue. It was hoped that the dsRNA homologue will provoke a 
strong cellular stress response, and this would translocate N
pro
 to the mRNPs. This way 
N
pro
 would be in the physical vicinity of the RNAi machinery, which is also localized in 
these granules. The results were surprising, however. As in previous experiments, N
pro
 
by itself did not suppress RNAi, however, polyI:C did in both the control and treatment 
cells. The addition of a long dsRNA homologue, which is a very strong stress signal for 
the cell indicating viral infection, suppressed the RNAi answer. This result raises the 
very intriguing possibility of a crosstalk mechanism between the ancient RNAi and the 
more recent protein-based innate immunity. 
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Figure 6.9 Northern blot analysis showed that N
pro
 does not suppress RNAi. The GAPDH 
knockdown assay was repeated and the RNA analyzed using Northern blotting. The results show that 
there is virtually no difference between control and Npro expressing cells. However, when polyI:C was 
added to the samples, we have seen a decrease of RNAi activity. The blot is a representative of many 
repeated experiments. a: control cells, b: mock treated cells, c: non-targeting siRNA treated cells, d: 
GAPDH siRNA treated cells, e: polyI:C treated cells, f: polyI:C/GAPDH siRNA treated cells. 18S RNA 
blot is shown for equal loading. 
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This result is in line with the study by Wiesen & Tomasi (2009) which showed 
down regulation of Dicer protein upon different cellular stress signals - such as the type 
I interferon response. With the GAPDH knockdown assay I have demonstrated a 
functional down regulation as well. 
6.4. Discussion 
Our hypothesis was that N
pro
, a viral interferon inhibitor protein, may have 
suppressing effect on RNAi. There were two reasons behind this hypothesis. First and 
foremost, our laboratory has shown that N
pro
 binds to and colocalizes with a cellular 
helicase, RNA Helicase A (RHA, DDX9). This helicase has been shown to be important 
in RISC loading, as the RNA interference machinery was shown to be defective in cells 
depleted of RHA (Robb & Rana 2007b). This suggested that by binding RHA, N
pro
 
might have a suppressing effect on RNA interference.  
The second reason was the available literature on mammalian RNAi suppressors. 
Many publications demonstrated that viral interferon inhibitors may show RNAi 
suppression activity. N
pro
, therefore, was an ideal candidate as a putative RNAi 
inhibitor. 
I have developed a functional RNA interference assay to assay the effectiveness of 
putative RNAi suppressors. The assay works by monitoring the level of a chosen 
housekeeping gene (GAPDH). Small inhibitory RNA against this housekeeping gene is 
transfected into the cells in a level which should silence the gene. Should any treatment 
suppress RNA interference, the level of GAPDH mRNA should be increased over the 
detection limit in siRNA treated samples as well. 
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The first method of detection was semi-quantitative limited cycle RT-PCR. The 
assay had to be optimized for each primers; it was important to stop the polymerase 
chain reaction in the exponential phase, before it enters the plateau phase. This way the 
relative strength of the bands of the PCR products would give an indication of their 
relative abundance in the samples. As a control I have chosen β-actin, and I was 
monitoring the levels of GAPDH and N
pro
 in different samples. 
The results were promising, as GAPDH mRNA was detected in GAPDH siRNA 
transfected N
pro
 expressing cells. This approach, however, is not ideal. It is only a semi-
quantitative method, and another problem is that it does not detect RNA levels directly. 
RNA has to be reverse transcribed into cDNA first; the subsequent amplification steps 
of the polymerase chain reaction amplify small impurities present. Northern blotting can 
detect RNA directly, and was used to verify the preliminary results of the RT-PCR 
reactions. 
Northern blotting, which detects RNA using end-labelled radioactive primer probes, 
found that N
pro
 does not affect RNA interference. Immunocytochemistry shows that N
pro
 
is diffused in the cytosol of transfected cells, while both RHA and the RNAi machinery 
are located in distinct cytoplasmic granules. By subjecting the cells to stress signals, we 
hoped to bring N
pro
 into these granules, so that it may be able to interact with RHA and 
other proteins.  
PolyI:C is a double stranded RNA homologue, and is widely used as an 
immunostimulant. Since double stranded RNA is a hallmark of viral replication, it is a 
very potent danger sign for the cell, which is detected by a host of different receptors 
(PKR, RIG-I, Toll-like receptor 3/7/8, OAS, etc.) By cotransfecting it into cells along 
with GAPDH siRNA it was hoped that any effects N
pro
 might have would materialize. 
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The results, however, showed that while N
pro
 did not have any effect on RNAi even 
under these circumstances, polyI:C itself did. As soon as the cells detected dsRNA, the 
effectiveness of siRNA mediated RNAi decreased, and the levels of GAPDH mRNA 
increased comparable to the control mRNA levels. This was a very intriguing and 
unexpected finding, which pointed to the possibility of crosstalk between RNA 
interference and the innate immunity. 
The study by Robb & Rana (2007b) identified RNA Helicase A as a crucial player 
in RISC loading. Using a similar knockdown assay they found that RHA depleted cells 
exhibit an impaired RNAi response. I repeated this experiment using both HEK293C 
and HeLa cells, but the results were the same in both cases: RHA depleted cells did not 
have any decrease in silencing efficiency. The assays used in both cases are very 
similar; the Robb study used a transgene (GFP) as an indicator and Lipofectamine 2000 
as a transfection reagent, whereas I used a housekeeping gene (GAPDH) and JetPrime. 
Nevertheless these factors do not explain the different results of the two studies. 
To establish where this crosstalk happens between the two systems, HEK293C cells 
were subjected to different types of cellular stresses before repeating the GAPDH assay 
again. Arsenate and type I interferons did not have any effect, whereas SINV infection 
was shown to repress the silencing machinery's efficiency. Both polyI:C and Sindbis 
virus had similar effects on RNA interference; this suggests that the effect is due to the 
cellular reaction to viral infection. The lack of effect upon arsenate stress suggests that 
the responsible pathway is not the PKR pathway, as both act through Eukaryotic 
Initiation Factor 2-α (eIF2α) phosphorylation and translational repression. Lack of 
effect of type I interferon stimulation suggests that the crosstalk between the innate 
immunity and the RNA interference machinery happens early in the interferon pathway. 
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This can happen possibly at the PAMP receptor level, before the stimulation of IFNAR. 
Both the cytosolic RNA sensors (RIG-I family of receptors) and Dicer are members of 
the DEAD box family of helicases, and act as PRRs in a diverse range of organisms 
from plants to mammals. These findings indicate a crosstalk between these proteins in 
mammalian cells that makes sure that Dicer activity does not diminish the pool of 
dsRNA available for PRRs of the immune system.  
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7. Discussion 
7.1. Overview 
As reviewed in Chapter 1, it is a well-established fact that in plants and invertebrates 
RNAi acts as a primary innate immune response against viruses. First, vsRNA can be 
isolated and characterized from these organisms. Second, if RNAi is rendered 
inoperable, viral yields increase. Third, viruses of these organisms encode RNAi 
suppressors (VSRs). Fourth, the RNAi response usually has either an amplification 
mechanism, or a way to spread the RNAi response between cells, or both. (A new study 
by Cohen & Xiong (2011) describes a mammalian mechanism that is capable of 
spreading the RNAi response.) Fifth, the genes of siRNA pathway evolve faster than the 
genes involved in the miRNA pathway, which indicates a sort of "arms race" between 
virus and host. (The scope of this study did not include analysis of the evolutionary 
speed of different mammalian and viral genes.) 
7.2. Cellular miRNA pathways are unaffected by SINV at the early 
stages of infection 
The sequencing results show that svRNA is not produced from the SINV genome by 
the RNAi machinery in infected cells, and this argues that svRNAs are not used in 
mammalian cells against SINV infection. Sindbis virus is a good choice to test this 
hypothesis, as it is a positive stranded RNA virus, readily infects a wide range of cells, 
and most importantly, it was demonstrated in mosquitoes that it lacks RNAi suppressors 
(Campbell et al. 2008). The abundance of RNA mapping to the SINV genome was low 
in the sequencing data, and none of these sequences could be verified with northern 
blotting, even though highly sensitive LNA and riboprobes were used. In organisms 
where the role of svRNA was confirmed (such as plants and invertebrates), high-
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throughput sequencing of virus infected cells results in very high number of reads 
mapping to the virus genome, which are readily detected using northern blotting. 
MicroRNAs were found not to be effected by SINV infection in the early stages of 
viral infection (0-6hpi). We have not managed to find differentially expressed miRNAs 
in the sequencing data, and northern blot verification only reinforced this result.  
7.3. siRNA pathway is suppressed in response to virus infection 
Double stranded RNA and SINV infection showed that the siRNA pathway is 
suppressed during RNA virus infection at 24hpi. This effect does not seem to be Dicer-
specific, as Dicer -/- cells show similar suppressing effect.  
Based on the sequencing data and the northern blot validations, we can also state 
that the miRNA pathway is not affected in the early stages of infection. Northern blot 
analyses performed on longer time-series experiments (0-24hpi) showed that the levels 
of selected miRNAs do not change (data not shown). This hints that the miRNA 
pathway is not affected on a longer time-scale, either.  
These results are incomplete and need further study to interpret them. My 
hypothesis for the siRNA pathway suppression is the importance of availability of 
dsRNA for the innate immune system (Figure 7.1). During the early stages of virus 
infection it is imperative that the cell effectively detects viral dsRNA. This might be 
assisted by the selective down regulation of the siRNA pathway, to prevent Dicer to 
process the long form of viral dsRNA into short fragments which are undetectable for 
the innate immunity. On the other hand, successful siRNA treatments are being 
developed against viral infections which demonstrate that the siRNA system is 
functional at some level, but only if it administered prior to infection. Unlike polyI:C, 
SINV infection did not cause complete suppression of the siRNA pathway. The 
137 | P a g e  
 
difference may be explained by the differences between the two treatments. PolyI:C is a 
very strong immune stimulant, and the cells were subjected to a high concentration; 
SINV infection, however is more close to the physiological conditions which virus 
infected cells are subjected to. 
High throughput sequencing should be repeated at later time points (16, 24, 72hpi) 
to establish the changes in miRNA expression profiles, and to look for potential vsRNA 
sequences. (The costs of sequencing have gone down considerably in the last year.)  
 
Figure 7.1. The proposed interaction between RNA interference and the innate immunity. dsRNA 
is a viral replication intermediate which is a substrate for Dicer and also a very important ligand for the 
pattern recognition receptors of the innate immunity. Dicer processes the long form of dsRNA (which is 
detectable to PRRs) into short, 20-23mer fragments, which are not detectable by the PRRs of innate 
immunity. This fact puts both systems into direct competition with each other for the same 
substrate/ligand, and a there needs to be a mechanism in place which enables the cell to prioritize the 
innate immune response when dsRNA is detected.  
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7.4. The lack of Dicer has an enhancing effect on SINV replication 
Studies on Sindbis replication showed several interesting phenomena. Dicer 
deficient cells showed a significant difference in accumulation of viral RNA and 
proteins, but this did not translate into higher viral loads. The reason for this is the fact 
that DLD-1 cells are not permissive to SINV release. Using a different Dicer -/- cell line 
would help to shed light onto this issue. The result that Dicer knockout cells are more 
permissible to viral infection corresponds to the findings of other studies (Triboulet et 
al. 2007). This, by itself, does not mean that RNAi acts in a similar way as in plants and 
invertebrates. MicroRNAs have been shown to have antiviral effects (C. H. Lecellier et 
al. 2005; Muller & J. L. Imler 2007), however it also has been argued that miRNAs 
cannot play a role in antiviral immunity, as viruses can evolve faster than the 
conservative miRNA sequences (Saumet & C.-H. Lecellier 2006). It is true that any 
exogenous sequence targeting by human miRNA is most likely a fortuitous exception to 
the rule, but microRNAs may have non-virus specific effects on helping the cell 
establish an antiviral state. Another possibility is that Dicer –and the lack of it- has an 
indirect effect on viral replication. Our results, however, showed no differentially 
expressed miRNAs in the early stages of infection in HEK293C cells.  
Dicer is an essential component of the cell homeostasis, which is demonstrated by 
the lethal phenotype of the Dicer -/- animals. The lack of Dicer –or even severely 
reduced Dicer activity- impacts the fitness of cells in a profound and negative way. This 
might cause the cells to be less able to mount an effective antiviral response, making it 
easier for the virus to replicate. 
7.5. The lack of RHA has an enhancing effect on SINV replication 
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RHA depleted cells were shown to be significantly more permissible for virus 
replication; the virus titres measured from RHA knockdown cells were higher than in 
control cells. This finding underlies the role of RHA in defence against alphaviruses. As 
previous studies demonstrated the role of RHA in RISC loading, and showed that RHA-
depleted cells have impeded RNAi response, there was a possibility that the observed 
effect of RHA above is carried out through the RNAi system, rather than the innate 
immunity. However, RHA-mediated RNAi suppression was not detected in our RNAi 
assay system under very similar circumstances. This suggests some sort of redundancy 
built into RISC loading system, or that RHA is not as essential as the previous study had 
shown. The cell types used, and the nature of the assay were very similar in both assays.  
Further studies are needed to determine how RHA affects viral replication.   
7.6. The lack of IRF3 has no effect on SINV replication 
N
pro
, a pestivirus protein, was used to decrease the levels of cellular IFR3, a crucial 
member of the signalling pathway leading to type I IFN-induction. The levels of IRF3 
and the presence of N
pro
 had no visible effect on viral loads. This argues that SINV 
already has mechanisms in place to inhibit the type I IFN response, and the addition of 
another IFN inhibitor, N
pro
, does not give a significant boost for the virus.  
7.7. Npro has no VSR function in mammalian cells 
Since many viral IFN inhibitors were shown to be putative VSRs, and N
pro
 was 
shown to interact with RHA, an important player in RISC loading, it was interesting to 
take a look at the role of N
pro
 in the RNAi process. Functional RNAi assay showed that 
neither N
pro
 nor RHA have any effect on silencing. However, when polyI:C, a synthetic 
double stranded RNA analogue was used, I found that RNAi is inhibited. PolyI:C was 
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used to help N
pro
 localize to stress granules, as it was expected that it might help it 
interact with the members of the RNAi machinery which are also localized here. The 
results were exactly the opposite expected: polyI:C by itself was enough to suppress 
silencing.  
Dicer -/- cell line helped to determine if this effect was the result overwhelming 
cells with dsRNA, which, in turn, saturated the RNAi pathway, or if it is the result of a 
specific crosstalk between RNAi system and the dsRNA sensors. The results from Dicer 
-/- cells indicate that the latter hypothesis is more likely. 
7.8. The next steps 
7.8.1. Sequencing 
Further experiments would include the repetition of sequencing at several time 
points (0-4-6-24-48-72hpi) in triplicates using several cell lines. The later time points 
would make it possible to monitor the longer-term changes in both miRNA and vsRNA 
profiles, and the biological replicates would make sure that any effect detected is 
reproducible.  
There is a possibility that later time points vsRNA may appear in the samples. This 
is unlikely; most authors who argue in favour of RNAi being a part of the innate 
immune response hypothesize that it serves as an immediate response until the protein 
based immunity takes over, but it is a possibility. It is also worth to sequence the small 
RNA populations isolated from different cell lines, as HEK293C is a tissue culture 
adapted line. Primary cells (HUVEC, for example), are attractive targets, and also 
embryonic stem cells, as they lack the IFN system and potentially use RNAi against 
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viral invaders. It would be very interesting to see if embryonic stem cells use RNAi 
against virus infection, unlike somatic cells from the same organism. 
7.8.2. Determination of the nature of crosstalk between innate immunity 
and RNAi 
The other important issue to address is the nature of the proposed crosstalk between 
the RNA interference machinery and innate immunity. There are no results yet that 
indicate the mechanism as of yet.  
My hypothesis is focused on Dicer as a potential partner in this crosstalk. Dicer 
belongs to the family of Dead/Box helicases, the same family of proteins where the 
RIG-I and MDA-5 cytoplasmic PAMP receptors belong to. In invertebrates and plants 
Dicer fulfils the same role as RIG-I does in mammals: detection of viral RNA and 
activation of antiviral signalling pathways. It has been proposed that these helicases are 
members of an evolutionary conserved group of PAMP receptors. It might be possible 
that Dicer is able to signal into any of the signalling pathways of the type I IFN 
response, or the other way around: mammalian PAMP receptor Dead/Box helicases 
communicate with the RNAi pathway. The fact that Dicer -/- cells show similar 
suppression of RNAi as the control cells, complicates this issue. It is important to 
remember, however, these cells do have Dicer present, but this protein has impeded 
dicing function due to a point mutation. It is possible that while Dicer is unable to 
effectively cleave RNA, it might still be able to play its role in the signalling pathways 
important for the RNAi suppressing effect. Using Dicer depleted cells, or cell lines 
where Dicer has been rendered dysfunctional in a different way, it might be possible to 
determine if this is the case. Another, related question is if human Dicer can distinguish 
between external, viral RNA and pre-miRNA. Organisms, in which RNAi has been 
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proven to be a form of innate immunity, have several Dicer homologues which have 
different –although overlapping- functions. 
Once these questions have been answered, it will be possible to map the exact 
signalling pathway leading to RNAi suppression. It is also possible to start looking for 
the connection between innate immunity and RNAi from the side of innate immunity. 
Cells, which are incapable of mounting an effective type I IFN response, showed higher 
concentration of vsRNA in studies. (Parameswaran et al. 2010) It would be interesting 
to see if RIG-I and other cytoplasmic PAMP receptor deficient cells produce vsRNA. 
As mentioned, embryonic stem cells are also very good candidates for cells that 
potentially use RNAi against viruses, as they do not mount interferon response, and 
have been shown to fight transposons and retro-transposons using RNAi.  
The next step is to determine is the mechanism of suppression. As described 
previously, other studies showed that the level of Dicer decreased in response to type I 
IFN and cellular stress. In my studies I have shown a functional suppression of the 
siRNA pathway as well, which worked in wild type and Dicer -/- cells. It is not yet 
certain which step of the RNAi response is suppressed, but these results indicate that the 
suppression works in multiple levels of the RNAi system. (Most likely the process of 
RISC loading, or RISC function itself is affected.) 
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